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Thermoplastics can be used as a replacement or alternative for a variety of 
medical and commercial products. The addition of halloysite nanotubes further enhance 
the strength and functionality of the composite. The aim of this project was to evaluate 
the capability polylactic acid (PLA) to be enhance with halloysite nanotubes and other 
additives. We created a nanocomposite that offered similar stabilization to titanium 
surgical plates but with the added benefit of bone generation through recruitment and 
differentiation of mesenchymal stem cells. Varying amounts of PLA and 
polycaprolactone were combined with growth factor doped halloysite nanotubes or 
silicon nitrate then extruded into 3D printer filament. Once 3D printed from the custom 
filament, the nanocomposite was subjected to mechanical and cell culture testing. Human 
mesenchymal stem cells were exposed to the 3D printed nanocomposites and monitored 
for osteogenic differentiation. 
Additionally, metalized halloysite nanotubes (mHNTs) were added to PLA to 
make an antibacterial 3D printer filament. Testing of both gentamicin loaded and 
unloaded mHNTs embedded PLA nanocomposites was conducted on E. coli and S. 
aureus. The PLA-mHNT filament was used to make a 3D printed antibacterial mask. 
Blow-spun fibers made of PLA and mHNTs were used as the filter component, which 




APPROVAL FOR SCHOLARLY DISSEMINATION 
The author grants to the Prescott Memorial Library of Louisiana Tech University 
the right to reproduce, by appropriate methods, upon request, any or all portions of this 
Dissertation. It is understood that “proper request” consists of the agreement, on the part 
of the requesting party, that said reproduction is for his personal use and that subsequent 
reproduction will not occur without written approval of the author of this Dissertation. 
Further, any portions of the Dissertation used in books, papers, and other works must be 
appropriately referenced to this Dissertation.  
Finally, the author of this Dissertation reserves the right to publish freely, in the 
literature, at any time, any or all portions of this Dissertation.  
 












This dissertation is dedicated to my family and friends. You all motivated me to 







TABLE OF CONTENTS 
ABSTRACT ....................................................................................................................... iii 
APPROVAL FOR SCHOLARLY DISSEMINATION .................................................... iv 
DEDICATION .................................................................................................................... v 
LIST OF FIGURES ........................................................................................................... xi 
LIST OF TABLES ........................................................................................................... xvi 
ACKNOWLEDGMENTS .............................................................................................. xvii 
CHAPTER 1 INTRODUCTION AND BACKGROUND ................................................. 1 
1.1 Industry Standard ................................................................................................ 1 
1.2 Drawbacks to Titanium ....................................................................................... 2 
1.3 Current Alternatives to Metal Implants .............................................................. 3 
1.4 Multifunctional Bioresorbable Implants ............................................................. 5 
1.5 Halloysite Nanotubes .......................................................................................... 6 
1.5.1 Properties ........................................................................................................ 6 
1.5.2 Biocompatibility ............................................................................................. 7 
1.6 Growth Factors ................................................................................................... 7 
1.6.1 TGF β1 ............................................................................................................ 7 
1.6.2 TGF β2 ............................................................................................................ 8 
1.6.3 TGF β3 ............................................................................................................ 8 
1.6.4 BMP2 .............................................................................................................. 9 
1.6.5 Silicon Nitride ................................................................................................. 9 





CHAPTER 2 3D PRINTING OVERVIEW ..................................................................... 13 
2.1 Types of 3D printing ......................................................................................... 13 
2.1.1 Powder Bed Inkjet Printing ................................................................. 13 
2.1.2 Stereolithography................................................................................. 14 
2.1.3 Selective Laser Sintering ..................................................................... 14 
2.1.4 Electron Beam Melting ........................................................................ 15 
2.1.5 Fused Deposition Modeling................................................................. 15 
2.2 Polymers ........................................................................................................... 17 
2.3 Infill .................................................................................................................. 20 
CHAPTER 3 POLYMER MIXTURE TESTING ............................................................ 22 
3.1 Introduction ....................................................................................................... 22 
3.2 Methods and Materials ...................................................................................... 25 
3.2.1 Growth Factor Hydration .............................................................................. 25 
3.2.2 Halloysite Loading ........................................................................................ 25 
3.2.3 Polymer Preparation...................................................................................... 26 
3.2.3.1 PLA Loaded HNTs Coating ................................................................ 26 
3.2.3.2 PLA Silicon Nitride Coating ............................................................... 27 
3.2.3.3 PLA:PCL with Loaded HNTs Coating ................................................ 27 
3.2.3.4 PLA:PCL with Silicon Nitride Coating ............................................... 28 
3.2.3.5 PLA Double Coating ........................................................................... 28 
3.2.3.6 80:20 PLA:PCL Double Coating ......................................................... 29 
3.2.4 Filament Extrusion ........................................................................................ 30 
3.2.5 Three-Point Bend Tests................................................................................. 31 
3.2.5.1 Bend Tests ........................................................................................... 31 





3.2.6 Nanocomposite Degratation for Bend and Failure Tests .............................. 32 
3.2.7 Degradation Testing ...................................................................................... 32 
3.2.8 Statistical Analysis ........................................................................................ 33 
3.3 Results and Discussion ..................................................................................... 34 
3.3.1 Extrusion Temperature.................................................................................. 34 
3.3.2 Strength Testing ............................................................................................ 35 
3.3.2.1 3-cm Bend............................................................................................ 35 
3.3.2.2 5-cm Bend............................................................................................ 37 
3.3.2.3 Break Tests .......................................................................................... 38 
3.3.3 Degradation Testing ...................................................................................... 44 
3.4 Conclusions ....................................................................................................... 47 
CHAPTER 4 CELL CULTURE STUDIES ..................................................................... 49 
4.1 Introduction ....................................................................................................... 49 
4.2 Methods ............................................................................................................ 50 
4.2.1 FITC/BSA Release Study ............................................................................. 50 
4.2.1.1 Making FITC/BSA Filament ............................................................... 51 
4.2.1.2 Nanocomposite Elution ....................................................................... 52 
4.2.1.3 FITC/BSA Concentration Collection .................................................. 52 
4.2.1.4 FITC/BSA Calibration Curve .............................................................. 52 
4.2.2 Cell Culture Media ........................................................................................ 53 
4.2.3 Cell Culture Proliferatiion............................................................................. 53 
4.2.4 Nanocomposite Printing and Preconditioning .............................................. 54 
4.2.5 Addition of Cells 48 Well Plate .................................................................... 54 
4.2.6 Live/Dead Staining ....................................................................................... 54 





4.3 Results ............................................................................................................... 56 
4.3.1 FITC/BSA Calibration Curve ....................................................................... 56 
4.3.2 FITC/BSA Release into Solution .................................................................. 56 
4.3.3 Live/Dead Staining ....................................................................................... 57 
4.3.4 Alizarin Red S Staining ................................................................................ 61 
4.4 Discussion and Conclusions ............................................................................. 62 
4.4.1 FITC/BSA Release........................................................................................ 62 
4.4.2 Live/Dead ...................................................................................................... 63 
4.4.3 Alizarin Red S Staining ................................................................................ 63 
4.5 Future Studies ................................................................................................... 64 
CHAPTER  5 ANTIBACTERIAL 3D FILAMENT AND FILTER ................................ 66 
5.1 Introduction ....................................................................................................... 66 
5.2 Materials and Methods ...................................................................................... 72 
5.2.1 Fabrication Design ........................................................................................ 72 
5.2.2 Inner and Outer Fabric Layers of the Filter .................................................. 72 
5.2.3 Material Preparation and Filament Extrusion ............................................... 73 
5.2.3.1 Metal HNT Preparation ....................................................................... 73 
5.2.3.2 HNT and mHNT PLA Filament Preparation ....................................... 74 
5.2.4 3D Printing of Masks .................................................................................... 75 
5.2.5 3D Printing of Test Discs .............................................................................. 75 
5.2.6 Antibacterial Testing ..................................................................................... 75 
5.2.6.1 Metal HNT Preparation ....................................................................... 76 
5.2.6.2 HNT and mHNT PLA Filament Preparation ....................................... 76 
5.2.7 Blow Spinning Fibers ................................................................................... 77 





5.2.7.2 Blow-Spun Fibers with Varying Amounts of mHNTs ........................ 77 
5.2.8 Distribution of mHNT in the Filter ............................................................... 78 
5.2.9 Filter Imaging................................................................................................ 78 
5.2.9.1 Scanning Electron Microscope (SEM) ................................................ 78 
5.2.9.2 Energy Dispersion Spectroscopy (EDS) .............................................. 78 
5.3 Results ............................................................................................................... 79 
5.3.1 SEM of mHNTs ............................................................................................ 79 
5.3.2 EDS of mHNTs ............................................................................................. 80 
5.3.3 Liquid Growth Inhibition Studies ................................................................. 80 
5.3.4 Plate Growth Inhibition Studies .................................................................... 86 
5.3.5 Filter SEM and EDS ..................................................................................... 89 
5.4 Discussion ......................................................................................................... 92 
5.4.1 Analysis of GS/mHNTs ................................................................................ 92 
5.4.2 Antimicrobial Studies ................................................................................... 92 
5.4.3 Filter Construction ........................................................................................ 94 













LIST OF FIGURES 
Figure 2-1: Illustration of the difference between direct and Bowden driven 3D 
printer head extruders. .……….….……….….…...……...……...………..….……….….17 
 
Figure 2-2: Illustration of the difference between bulk and surface erosion due to 
polymer hydrolysis. ...……………………………………………………………………18 
 
Figure 3-1: Diagram of the loading of halloysite nanotubes process. ..……….…...........26 
 
Figure 3-2: Rendering of the shape to make the 3D print for the 3-point bend tests.  
Each square represents 1mm2. The dimensions are 56mm x 8mm x 2.5mm. .….....…..…31 
 
Figure 3-3: Rendering of the shape to make the 3D print for the degradation and  
elution tests. Each square represents 1mm2. The maximum dimensions are 25mm x 
14mm x 3mm. ………………….………………………………………………………...33 
 
Figure 3-4: The graphs of the force exerted upon the nanocomposites during the 3cm  
3-point bend test for (A) PLA, (B) 80:20, (C) 70:30, and (D) 60:40 polymer blends.  
Error bars represent the standard deviation of the peaks. (n=3). .………………………. 36 
 
Figure 3-5: A composite of the forces exerted onto the nanocomposites during the 3-
point bending test. Each line represents the average of 3 tests. …………………………36 
 
Figure 3-6: A composite of the forces exerted onto the nanocomposites during the  
5cm 3-point bending test. Each line represents the average of 3 tests. ………………….38 
 
Figure 3-7: Force (N) to break the nanocomposite after a degradation period of 0  
weeks. Each line is the average of exerted force. Each dot is the maximum force  
applied with respect to distance before failure. ………………….………………………39 
 
Figure 3-8: Force (N) to break the nanocomposite after a degradation period of 6  
weeks. Each line is the average of exerted force. Each dot is the maximum force  
applied with respect to distance before failure. ………….………………………………39 
  
Figure 3-9: Force (N) to break the nanocomposite after a degradation period of 12 
weeks. Each line is the average of exerted force. Each dot is the maximum force  
applied with respect to distance before failure. …………….……………………………40 
 
 





period of 0 weeks. Error bars represent the standard deviation. (n=3). …...………....……41 
 
Figure 3-11: Average work needed to destroy the nanocomposite after a degradation 
period of 6 weeks. Error bars represent the standard deviation. (n=3). ……….…………42 
 
Figure 3-12: Average work needed to destroy the nanocomposite after a degradation  
period of 12 weeks. Error bars represent the standard deviation. (n=3). …………….…..42 
 
Figure 3-13: Graph of work needed to destroy each blend of nanocomposite after 
degrading for 0-, 6-, and 12-weeks. The slope of each line represents the trendline of  
each nanocomposite. (n=3 for each point). ………..……………………………………..43 
 
Figure 3-14: Absorbance recorded at 230 nm to characterize lactic acid in PBS over a 
20-week period for the PLA nanocomposite. Error bars represent standard deviation. 
(n=6). ……………………………………………….……………………………………45 
 
Figure 3-15: Absorbance recorded at 230 nm to characterize lactic acid in PBS over a 
20-week period for the 80:20 blend nanocomposite. Error bars represent standard 
deviation. (n=6). …………………………………………………………………………45 
 
Figure 3-16: Absorbances recorded at 270 nm to characterize ꞓ-capronic acid in  
PBS over a 20-week period for the 80:20 blend nanocomposite. Error bars represent 
standard deviation. (n=6). ……….……………………………………………………….46 
 
Figure 3-17: Absorbance values of the combined ꞓ-capronic and lactic acid in PBS  
over a 20-week period for the 80:20 blend nanocomposite. Error bars represent the 
combined standard deviations. (n=6). ………………….……………………….….…….47 
 
Figure 3-18: Graph showing the values associated with the hydrolysis of each 
nanocomposite. …………………….…………………………………………………….48 
 
Figure 4-1: Graph of the calibration curve of FITC/BSA in PBS to determine the  
amount of FITC/BSA released from the nanocomposite over time. ……...……………..57 
 
Figure 4-2: Graph of FITC/BSA released from cylindrical nanocomposites after  
degradation. Error bars represent ± standard deviation. (n=6). ……….……..…………..57  
 
Figure 4-3: FITC/BSA released into solution after nanocomposite degradation in  
4-week intervals. .…….…….…..………………..………………………………………58 
 
Figure 4-4: Live dead assay of the control wells showing the live cells in green on top 
image and dead cells in red on the image below for day 1, 7, 14, 21, and 28. ..................58 
 
Figure 4-5: Live dead assay of wells containing HNT\PLA discs showing the live  
cells in green on top image and dead cells in red on the image below for day 1, 7, 14,  






Figure 4-6: Live dead assay of wells containing TGFβ1\PLA discs showing the live  
cells in green on top image and dead cells in red on the image below for day 1, 7, 14,  
21, and 28. .........................................................................................................................59 
 
Figure 4-7: Live dead assay of wells containing TGFβ2\PLA discs showing the live  
cells in green on top image and dead cells in red on the image below for day 1, 7, 14,  
21, and 28. .........................................................................................................................60 
  
Figure 4-8: Live dead assay of wells containing TGFβ3\PLA discs showing the live  
cells in green on top image and dead cells in red on the image below for day 1, 7, 14,  
21, and 28. .........................................................................................................................60 
  
Figure 4-9: Live dead assay of wells containing BMP2\PLA discs showing the live  
cells in green on top image and dead cells in red on the image below for day 1, 7, 14,  
21, and 28. .........................................................................................................................61 
  
Figure 4-10: Live dead assay of wells containing silicon nitride\PLA discs showing  
the live cells in green on top image and dead cells in red on the image below for day  
1, 7, 14, 21, and 28. ............................................................................................................61 
 
Figure 4-11: Graph showing the quantitative values of cell count calculated (live 
cell/total cell count). Error bars are standard deviation where n=3. ....................................62 
 
Figure 4-12: Alizarin Red S staining of each well after days 1, 7, 14, 21, and 28 days  
of exposure to nanocomposite. ..........................................................................................62 
 
Figure 4-13: Alizarin Red S staining of each well after 35 days of exposure to  
nanocomposite. ..................................................................................................................63 
 
Figure 5-1: Schematic of the halloysite metal coating process. .......................................75 
 
Figure 5-2: Scanning electron microscope image of A) silver, B) copper, and C) zinc 
coated halloysite nanotubes. ..............................................................................................80 
 
Figure 5-3: Energy dispersion X-ray spectroscopy scan of A) silver, B) copper, and  
C) zinc coated halloysite nanotubes. .................................................................................81 
 
Figure 5-4: PLA beads coated with mHNTs in Mueller-Hinton broth for 48h with  
E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars  
represent ± standard deviation. Values had a significant difference unless denoted  









Figure 5-5: PLA beads coated with doped mHNTs in Mueller-Hinton broth for 24h  
with E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars 
represent ± standard deviation. Values had a significant difference unless denoted  
(p<0.05). (n=3). .................................................................................................................83 
 
Figure 5-6: PLA beads coated with doped mHNTs in Mueller-Hinton broth for 48h  
with E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars 
represent ± standard deviation. Values had a significant difference unless denoted  
(p<0.05). (n=3). .................................................................................................................84  
 
Figure 5-7: PLA beads coated with GS doped mHNTs in Mueller-Hinton broth for  
48h with E. coli. Optical density readings were taken at 24 and 48h. Optical density  
was taken at 630nm wavelength. (mean, n=3). .................................................................84 
 
Figure 5-8: PLA beads coated with GS doped mHNTs in Mueller-Hinton broth for  
48h with S. aureus. Optical density readings were taken at 24 and 48h. Optical density 
was taken at 630nm wavelength. (mean, n=3). .................................................................85 
 
Figure 5-9: GS doped 3D printed mHNTs discs in Mueller-Hinton broth for 24h  
with E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars 
represent ± standard deviation. Values had a significant difference unless denoted  
(p<0.05). (n=3). .................................................................................................................86 
 
Figure 5-10: GS doped 3D printed mHNTs discs in Mueller-Hinton broth for 48h  
with E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars  
represent ± standard deviation. Values had a significant difference unless denoted  
(p<0.05). (n=3). .................................................................................................................86 
 
Figure 5-11: 3D printed PLA with GS doped mHNTs in Mueller-Hinton broth for  
48h with E. coli. Optical density readings were taken at 24 and 48h. Optical density  
was taken at 630nm wavelength. (mean, n=3). .................................................................87 
 
Figure 5-12: 3D printed PLA with GS doped mHNTs in Mueller-Hinton broth for  
48h with S. aureus. Optical density readings were taken at 24 and 48h. Optical  
density was taken at 630nm wavelength. (mean, n=3). ......................................................87 
 
Figure 5-13: Zone of inhibition diameter average for each respective 3D printed discs  
after 24h. Error bars represent ± standard deviation. Values had a significant  
difference unless denoted (p<0.05). (n=3). ........................................................................88 
 
Figure 5-14: Mueller-Hinton agar plates, plated with E. coli, and (A) nothing, (B) 
PLA/HNT, (C) 3D printed GS/Ag/HNT disc, (D) 3D printed GS/Cu/HNT disc, (E)  







Figure 5-15: Mueller-Hinton agar plates, plated with S. aureus, and (A) nothing, (B) 
PLA/HNT, (C) 3D printed GS/Ag/HNT disc, (D) 3D printed GS/Cu/HNT disc, (E)  
3D printed GS/Zn/HNT disc, (F) 3D printed GS/Ag,Cu,Zn/HNT disc. .............................89 
 
Figure 5-16: Zone of inhibition diameter average for each respective 3D printed discs 
after 24h. These were GS loaded mHNTs. Error bars represent ± standard deviation.  
Values had a significant difference unless denoted (p<0.05). (n = 3). ..............................90 
 
Figure 5-17: SEM of filter using the 0.1g/mL mixture PLA solution. ...............................90 
 
Figure 5-18: SEM of filter using the 0.075g/mL mixture PLA solution. ...........................91 
 
Figure 5-19: SEM of filter using the 0.05g/mL mixture PLA solution. .............................91 
 
Figure 5-20: EDS of 10% CuHNT to PLA blow-spun fibers. ...........................................92 
 
Figure 5-21: EDS of 20% CuHNT to PLA blow-spun fibers. ...........................................92 
 
Figure 5-22: EDS of 30% CuHNT to PLA blow-spun fibers. ..........................................93 
 
Figure 5-23: Graph showing the coverage of representative piece of each filter. Error  
bars represent standard deviation. Values had a significant difference unless  










LIST OF TABLES 
Table 3-1: The extrusion temperature and diameter of each filament composition.  
Filament measurements were taken every meter. 30 measurements were taken to  









These projects were possible because of the mentorship, dedication and 
encouragement of my advisor and mentor Dr. David K. Mills. I further acknowledge the 
work put forth by my lab mates to help me succeed in graduate school. I hope I have helped 









INTRODUCTION AND BACKGROUND 
1.1 Industry Standard 
With the gaining popularity of using biologically safe polymers in the medical 
industry, we aim to develop an alternative option to titanium to fixate and stabilize 
fractured bone. A polymer blend with an enhanced capability to aid in bone regeneration 
could be the alternative that patients choose over titanium. Surgical implants to preserve 
fractures have come a long way in a relatively short period. Alloys of vitallium and 
stainless steel were used for several years but had drawbacks. Stainless steel was the 
leading manufacturing material. However, testing showed that in many cases, it was 
inferior to titanium [1]. Stainless steel screws tended to loosen or even breaking before 
the fracture had been stabilized completely [2]. It was believed that infection played a 
role in the failure of the stainless-steel implants, but these complications could occur even 
without disease affecting the screws or surrounding bone [2]. Regardless of that fact, the 
infection was not typically observed when titanium was used instead of stainless steel.  
Additionally, titanium is about 40 percent lighter than stainless steel, making it 
less taxing on the implant recipient [2]. The utilization of titanium made stainless steel 
obsolete. The industry standard for reattaching tendons and ligaments has been relatively 
the same for the past five decades. Titanium is a robust metal that is the leading implant 





other objects in the body. Titanium surgical screws have been used to attach tissues to the 
bone to closely mimic previous attachment’s structure, strength, and functionality of the. 
These suture anchors are used to attach ligaments or tendons to the bone by drilling holes 
directly into the existing bone. While titanium has been at the forefront of medical device 
manufacturing, improvements can be made in designing medical devices. 
1.2 Drawbacks to Titanium 
         Complications of titanium, when used in vivo, can range from but are not limited 
to, chondrolysis, synovitis, osteolysis, or even device failure [3]. Chondrolysis and 
osteolysis typically did not occur due to nanoparticles leaching over time or general wear 
and tear of the titanium device. Instead, micro-shavings from the insertion of the titanium 
screws enter adjacent cells and cause lysis. Once the structural integrity is restored 
following the titanium implant fixation, implant removal becomes an option [4]. Ten 
percent of titanium implant recipients have concerns about infection and thermal 
sensitivity in European countries, while United States patients are wary about eventual 
pain, soreness, tenderness, and disease [4]. In both cases, the 10 percent elect to have 
their titanium implants removed [4]. Unfortunately, the removal of titanium implants is 
not a simple task. Osseointegration, a condition in which bone grows over or onto the 
implant, may occur, leading to the need to remove healthy bone to remove screws or 
plates [4].  
An additional complication could arise if implant breakage happens [5]. Frisken et 
al. had data to support that implant failure may result in considerably more titanium 
migrating to proximal lymph nodes. In the study, a 17 percent failure rate was observed 





needs to be taken when using titanium braces in elderly patients due to an increased 
possibility of the patient having higher levels of demineralized bone matrix [6]. Biofilms 
can form on the titanium implants surface if their surface is not pristine and exhibits any 
surface roughness [7]. Infections can arise from surface biofilms or compromised 
immune capabilities due to a surface protein layer that is formed, which makes for a 
suitable adhesion point for bacterial growth. Biofilms can be formed as soon as 30 
minutes after implantation and an increase in thickness and colonies over time [8]. 
Growth of the bacterial biofilm can not only lead to infection but device weakening and 
device failure as well.   
1.3 Current Alternatives to Metal Implants 
         Advancements in medical technology have made the use of new materials for the 
manufacturing of structural screws, stabilization plates, and wound sutures. Polymers 
provide an alternative to the traditional metal in which these products were developed. 
Careful considerations were taken into the selection process that determines which 
polymers are used for in vivo applications. Special care and testing, in conjunction with 
the Food and Drug Administration (FDA), ensure that the polymeric compounds that 
comprise future implants are non-cytotoxic and biocompatible. 
The ability to have a 3D printable substance that acts as a scaffold and is later 
absorbed is the main focus of bioresorbable materials. The scaffold should have specific 
properties such as controllable porosity, resorbability, and non-toxicity in an in vivo 
environment.[9] Recently, research has been done on many different uses for 
bioresorbable materials with the properties listed above. One area is in the world of 





outperform the current metallic stents that are currently being utilized [10]. The new 
technology is essential because, with the current stents, there are some adverse biological 
side effects an device reliability issues that include but are not limited to in-stent 
restenosis and late stent thrombosis [11].  
Continuing with research to replace metallic structures with ones made of 
polymers, Gaball et al. found a bioabsorbable bone plate that exhibited the same strength 
yet more flexibility of similar bone plates made of titanium [12]. The research showed 
that the polymers poly(L-lactide-co-D) and poly(L-lactide), when combined at a specific 
ratio, could be used as a viable replacement option for stabilization of non-weight bearing 
bones and joints such as the mandibular joint [12]. A study found that these polymers 
were slightly osteogenic and were completely resorbed once replaced by newly grown 
bone [13].  
Other lines of research that bioresorbable materials are being utilized are in the 
field of bone and tissue repair or replacement instead of solely fixating. Bioresorbable 
polymeric scaffolds have an excellent potential for revolutionizing the way bones, 
cartilage, and musculoskeletal tissues can be printed and replaced in the human body 
[14]. The scaffolds would be used to promote cell growth of the host's own newly made 
cells as a replacement for defective or absent tissues. These scaffolds are different from 
the stabilization plates and screws because the original tissue is wholly or partially 
removed and replaced with the 3D printed construct. The human body has a remarkable 
ability to repair itself after it has sustained damage. Tissues tend to be more comfortable 






1.4 Multifunctional Bioresorbable Implants 
An implant can be deemed multifunctional if it performs more than a singular 
primary purpose, for example, structure and active regeneration. To facilitate a 
bifunctionality such as this, the bone plate would have to contain a substance that 
promoted cell proliferation and differentiation. Various components that facilitate new 
bone growth, which acts as a repair mechanism for the damaged bone. Some of these 
components include growth factors or morphogenetic protein, and when coupled with an 
adequate blood circulation near the site, new bone can be formed [15]. The particular 
growth factors and morphogenetic protein typically being utilized for osteogenic and 
chondrogenic development were TGF-β1, TGF-β2, TGF-β3, and BMP, respectively [15].  
Several release mechanisms are available for releasing drugs, proteins, or growth 
factors encapsulated in implants. Uhrich et al. (1999) researched different mechanisms to 
release beneficial drugs encapsulated in polymers [16]. Diffusion controlled release 
involves an insoluble polymer with a complex pore structure in which the encapsulated 
drug must navigate to reach the surface to become active [16]. Flow regulated release is 
mainly controlled by osmotic pressure in the host's body using a semipermeable polymer 
[16]. External pressure is exerted onto the polymer, causing the polymer to release some 
of the internal drugs, which it was embedded to equalize the pressure [16]. Typically, 
controlled release involves a release of drugs at a constant rate. The polymer 
encapsulated drug is controllably released through a system of premade channels in a 
dissolvable polymer [16].  
Studies have shown that the concept of bioresorbable polymers embedded with 





materials can be made to release these growth factors with a precise dosage over some 
time [15]. Furthermore, it was concluded that the soft tissue’s success rate to bone repair 
could be improved by further exploring suturing implants composed of tri-calcium 
phosphate and poly-etheretherketones.   
The surface erosion mechanism closely resembles the mechanism that we are 
aiming to achieve. Hydrolysis occurs for the outside moving inward, releasing the 
encapsulated substance in specific dosages over some time [16]. The release of the 
growth factors from halloysite over time due to the polymer’s biodegradation and the 
subsequent resorption of the polymers' monomers is the main focus of my research. 
1.5 Halloysite Nanotubes 
1.5.1  Properties 
 Halloysite is a natural occurring aluminosilicate that is mined in several locations 
around the world. It self-assembles into a hollow tube shape when exposed to water 
known as a halloysite nanotubes (HNTs). HNTs have an inner lumen diameter of 15-20 
nm, an outer diameter of 30-70 nm, and a length of 100-2000 nm [18]. The alumina layer 
of the outer surface of the HNT is negatively charged and the surface of the inner lumen 
has a silica layer that is positively charged. The charged surface of HNTs allow for 
surface modification by attaching ions, ligands surfactants, or polyelectrolytes. 
Substances with an overall positive or neutral charge such as antibiotics, proteins, and 
hormones can be loaded inside the lumen. HNTs can hold approximately 10% by volume 







1.5.2  Biocompatibility  
 Based on a numerous amount of research HNTs have been shown to be 
biocompatible and non-cytotoxic [18]. Extensive research was conducted to explore the 
use of HNTs as delivery systems for antimicrobial and chemotherapeutic agents due to 
their sustained release over time. Cell cultures using fibroblast, pro-osteoblast, and 
mesenchymal stem cells done by our research team have shown no cytotoxic effects due 
to HNTs.   
1.6 Growth Factors 
1.6.1   TGF β1 
Transforming growth factor-beta 1 (TGF β1) is one of many growth factors 
released during bone resorption mediated by osteoclast. Growth factors are released 
during this process of bone degradation to facilitate the formation of newer, more healthy 
bone tissue [19]. Tienlinen et al. (1999) demonstrated that when TGF β1 was delivered 
directly to an affected area by a degradable lactide pin, aided in bone formation [17]. 
TGF β1 is an abundant growth factor in the bone matrix that is released to stimulate the 
migration of bone marrow-derived mesenchymal stem cells to the site of bone resorption 
by the osteoclasts [19].  
The effects of having an abundance of TGF β1 due to its release and activation by 
osteoclasts have an impact on deterring activity of more osteoclast as a way of balancing 
the degradation of bone. Metered distribution of TGF β1 is needed because overexposure 
to TGF β1 over an extended time can lead to excessive bone thickening because of the 
inhibition of osteoclast precursors, thus disrupting a healthy bone regeneration cycle [19]. 





several diseases that can lead to deafness, blindness, or induced myopathy due to overly 
dense bones [17], [19].  
 1.6.2   TGF β2 
Using TGF β2 specific gene-probes, Millan et al. (1991) showed that the 
expression of TGF β2 is present mainly in the chondroblast zones of long bones and not 
in mature cartilage or areas of endochondral or intramembranous ossification [20]. 
Growth in these zones is characteristic of average pre-adulthood growth plate growth. 
Similarly, Schmid et al. (1991) used a TGF β2 riboprobe to explore the expression of 
TGF β2 and found that it was mainly present in growth zones of limbs in a study done on 
mice during embryogenesis [21]. These studies suggest that TGF β2 is an initiator of 
chondrogenesis and ossification in some bone regions. Additionally, cell proliferation 
was elevated in coronal sutures and calvarial bones when exposed to TGF β2 [22].   
1.6.3   TGF β3 
The primary mesenchymal stem cell (MSC) response to TGF β3 is an increase in 
cell proliferation. More specifically, James et al. (2009) showed that TGF β3 could affect 
chondrogenesis by enhancing the chondroprogenitor cell expression [23]. Matsike et al. 
(2015) developed a method using TGF β3 to differentiate MSCs into chondrocytes [24]. 
In both cases, TGF β3 was isolated and introduced to stem cells and successfully showed 
cell proliferation and differentiation in the pathway that resulted in chondrogenic 
formation. Kim et al. (2012) showed that a slow, sustained release of TGF β3 over nine 
weeks had comparable results as the growth of cells exposed to a high concentration 






1.6.4   BMP2 
Bone morphogenetic proteins are widely used as a stem cell differentiator for 
chondrogenesis and osteogenesis. Bone morphogenetic protein 2 (BMP2) is one of many 
cytokines that can cause MSC to differentiate into osteoblasts when used in in vitro 
experiments and induce in vivo bone growth [26]. BMP2 activates skeletal-related genes 
for the formation of cartilage and bone in more than just mesenchymal cells [27]. BMP2 
exposed stem cells showed early stages of commitment and differentiation to the 
osteoblast phenotype [27]. Katagili et al. (1994) showed that BMP2 could differentiate 
myoblasts into osteoblast when implanted into muscular tissue [28].      
1.6.5   Silicon Nitride 
Silicon nitride is being explored for its ability to differentiate cells into bone. It is 
currently being used clinically due to its characteristic non-cytotoxicity and robustness 
[29]–[32]. A study conducted by Guedes e Silva et al. (2007) showed osteogenic growth 
due to silicon nitride through the presence of newly formed bone bridges that grew 
towards and on the surface of the implant [29]. Pezzotti et al. (2017) confirmed through 
histomorphometric analyses that the growth of new bone was due to silicon nitride 
degradation and subsequent ion release as demonstrated by Fourier-transform-infrared 
(FTIR), Raman, and X-ray photoelectron spectroscopy. 
Silicon nitride particles have shown that they dissolve in polar liquids such as 
phosphate-buffered saline or blood. Adsorption of the silicon nitride components into 
blood plasma indicated an excellent acceptance of into the body with a relatively low 
immune response [30]. The subsequent release of silicic acid and nitrogen compounds 





(2009) demonstrated the cytocompatibility of silicon nitride with live/dead staining of 
human mesenchymal stem cells and mouse fibroblast cells in a cell culture study [34]. 
Not only is silicon nitride non-toxic, but it encourages cell adhesion, differentiation, and 
normal proliferation [35]. The results of a survey conducted by Pezzotti et al. (2017) 
connected osseointegration behavior with Si and N elements, which stimulated progenitor 
cell differentiation and osteoblastic activity, ultimately resulting in accelerated bone 
ingrowth [33]. Guedes e Silva et al. (2007) conducted a study using rabbits that revealed 
that silicon nitride would induce differentiation of cells into bone tissue containing 
osteocytes and osteons. In the 8-week study, the osteogenic process intensified at the 4-
week mark [29].  
Additionally, silicon nitride has shown an ability to deter bacterial growth in vivo 
while inducing the growth of healthy new bone tissue in rat studies [36]. During the 
investigation, Webster et al. compared the potential to grow new bone around silicon 
nitride, poly (ether ether) ketone (PEEK), and titanium both with and without inducing a 
bacterial infection with Staphylococcus epidermidis [36]. While the study showed a 
decrease in bone formation in the infected rats, there were no live bacteria adjacent to the 
silicon nitride, unlike in the PEEK and titanium [36].   
1.7 Design Elements 
         A combination of bioresorbable polymers, halloysite nanotubes and growth 
factors comprised the device that aimed to replace the structural function of titanium. 
Careful consideration was taken to include components that would add to the 
effectiveness, either structurally or osteogenically. The research that was conducted 





implants exhibits. Some of these challenges include a reduced ability to withstand shear 
forces, raw material costs, and limitations with machining the implantable material. The 
overall design elements were carefully chosen to develop a nanocomposite with adequate 
strength and flexibility to fixate bone while being able to eventually dissolve as it 
promotes osteogenesis or chondrogenesis, leading to full osteointegration, eventually 
replacing the nanocomposite with newly grown bone. 
Firstly, the ratio of which polymers to blend was investigated. This was important 
because the nanocomposite, at the very least, must be able to stabilize the fractured bone. 
Secondly, we decided which morphogens to use that would drive mesenchymal stem 
cells to differentiate into the pathway that would eventually grow into bone or cartilage. 
Individual proteins from the transforming growth factor superfamily were investigated 
for possible inclusion in the nanocomposite design. The compound silicon nitride was 
also used in this study to evaluate its effectiveness in differentiating stem cells into a 
lineage that would result in the formation of osteocytes. The growth factors were to be 
contained within the halloysite nanotubes, which acted as a biocompatible nanocontainer 
and aided structurally within the nanocomposite.    
The shape selection of the nanocomposite is of high importance to the implant’s 
success once it is in vivo. Special consideration was taken to mimic the preexisting shape 
of titanium bone fixation plates. To facilitate the stabilization of bone post-fracture, 
several shapes of titanium are currently being used. Each has its inherent benefits. 
Selecting the appropriate size, shape, and thickness of the titanium plate is crucial. 
Accounting for loads on the device such as in vivo forces, interfacial tissue response, 





The use of screws instead of pins can be more beneficial to the implant recipient. A 10-
year study conducted by Karoussis et al. (2004) showed that having a lumen within a 
screw-like shape was better than a hollow cylinder in terms of the overall success of the 
implant [38]. They remarked that their patient sample showed a significantly higher 
survival rate for the implant, lower instances of biological complications such as 
mucositis and peri-implantitis. 
One of the first factors that must be determined is whether the bone and, 
therefore, the titanium implant, is weight-bearing. If a weight-bearing bone is fractured, 
the implant must be more robust to withstand the weight of the individual once they are 
healed. Non-weight bearing bone fractures can use thinner titanium plates, as their 
strength typically does not need to be as high. The infill ratio and pattern of infill as 
crucial as the shape of the nanocomposite. These two factors are what give the 
nanocomposite its strength and ability to support cell growth. A proper balance of power 
and the porosity, along with wall layers, had to be taken into consideration when 
designing the nanocomposite. For this study, we only considered non-weight bearing 
bone fractures. In each case, implant shape and the characteristics can have an impact on 
the effectiveness of an implant over time. Extensive research has been done on the shape, 
size, and composition of bone fixating surgical implants, as it will directly relate to the 







3D PRINTING OVERVIEW 
2.1 Types of 3D Printing 
3D printing and additive manufacturing are terms that encompass several different 
techniques to take a material and form it into a construct. These constructs are typically 
designed using a rendering software that plans the printer’s every movement and 
produces a printing code. Some of the techniques include powder bed inkjet printing, 
stereolithography (SLA), selective laser sintering (SLS), electron beam melting (EBM), 
and fused deposition modeling (FDM). Each printing technique has benefits, drawbacks 
and limitations. 
2.1.1   Powder Bed Inkjet Printing 
In powder bed inkjet printing, the print head deposits a binding liquid, layer by 
layer, in a predetermined pattern onto a bed of powder according to the computer-aided 
design (CAD) instructions. The binding liquid is then covered in a thin layer of powder to 
complete the section. The process is repeated until the model is complete, with each 
successive layer bound to the previous layer. The next step is to de-powder the model, 
which involves spraying, blowing, or washing the newly made model with a solvent or 
air to remove the unbound powder. The main drawbacks for powder bed inkjet printed 
objects are that they are highly porous, ununiform ,can be brittle, or may require 




 application without further research done on the interaction of biodegradable binding 
liquid and a powdered blend of polymer, growth factor and growth factor container. 
2.1.2   Stereolithography         
 Stereolithography (SLA) is a 3D printing technique that uses a photochemical 
process to bind oligomers and monomers to produce longer polymers. The light-sensitive 
monomers and oligomers in liquid form are exposed to light, which crosslinks them, 
forming a solid polymer. After a layer is photo-polymerized, the build platform is moved 
back to the resin pool. A new layer of oligomer and monomer mixture is coated onto the 
surface to begin the next layer. Hydrogels are being used to replicate soft tissues using a 
similar process [41]. The main drawbacks of SLA are that the polymer that is produced 
may not be uniformed, the final model may need additional curing, the resins are 
typically not biodegradable, and hydrogel prints are typically not rigid [42], [43]. These 
attributes rule stereolithography out as a means of manufacturing the desired 
nanocomposite. Stress fractures or failure of the implanted device could occur due to 
inconsistent polymer chains. Additional curing could damage growth factors embedded 
within the nanocomposite.  
2.1.3   Selective Laser Sintering  
Selective laser sintering (SLS) is a technique that uses thermal energy supplied by 
a focused laser beam as its primary mechanism to facilitate the sintering of substrates 
such as nylon or polyamides. The powdered substrate is bound together at a single point 
in space predetermined by 3D modeling software to construct a solid model using a beam 
deflection system such as Galvano mirrors. This process should not be confused with the 




instead of powders. SLS has identical drawbacks as SLA, but models made using SLS are 
typically less brittle than those made with the SLA printing method [44]. Selective laser 
sintering was ruled out due to the thermal energy needed for the process. A 
nanocomposite using silicon nitride could be made using this process. 
2.1.4   Electron Beam Melting 
Electron beam melting (EBM) is a high energy 3D printing technique in which 
raw materials such as wire or metal powder are placed under a vacuum and fused. The 
fusion is done by completely melting the substrate unlike in SLS. The process is typically 
done at a higher temperature than the other 3D printing techniques which aids in reducing 
porosity and increases mechanical properties. The main drawbacks are that EBM is 
generally only used for the manufacturing of metal parts, like titanium braces, due to its 
high-temperature demand [45], [46].  
2.1.5   Fused Deposition Modeling 
Fused deposition modeling (FDM) is the 3D printing technique that uses a 
continuous spool of thermoplastic filament to manufacture models. The process entails 
momentarily melting the thermoplastic polymer and directly extruding it onto the build 
plate or the previously made layer. Precise heating and cooling of the thermoplastic are 
vital in preventing warping, adding sufficient detail, and producing the desired porosity. 
There are several different designs of FDM printers, but two design parameters offer 
distinction between machines. The most important difference in design is the driving 
mechanism to feed filament to the hot end of the extruder head. Direct drive is typically 
less accurate than Bowden driven printers due to the added weight of the driving motor 




between the feeding gear and the printer head. Direct drive printers typically have less 
stringing when compared to Bowden driven printers. Stringing is misprinted, extra 
material between two spans of a 3D print. Stringing can be minimized with fine-tuning of 
temperature and filament retraction distance during printing. Figure 2-1 illustrates the 
difference between the two printer head styles.    
The second significant distinction between 3D printers is the number of printer 
head freedoms. This term refers to the number of axes the print head is responsible for 
covering, between 1 and 3. 2 degrees of freedom is typically more accurate than 1 or 3 if 
one of the freedoms is in the z axis. The main drawback for FDM is that misprints are 
common, prints are time-consuming, and there may be a need of printing supports. The 
main advantages of FDM are that there is a broader range of materials that can be used 
with this printing method, the printers are typically less expensive, and the printing 








Figure 2-1: Illustration of the difference between direct and Bowden driven 3D 
printer head extruders.   
2.2 Polymers 
Polymers can be divided into two categories, biodegradable and non-
biodegradable. Non-biodegradable polymers withstand breakdown under normal 
biological conditions. Biodegradable polymers are polymers that, when exposed to 
biological conditions, begin to deteriorate through a process called hydrolysis. A 
hydroxyl and carboxylic acid group is formed due to the hydrolysis of the ester bond of 
the polyester backbone [47]. There is a cascade effect in which the breaking of one 
monomer chain causes the breakdown of another. This is known as autocatalytic 
hydrolysis in which the primary reaction for the breakdown of the polymer is facilitated 
by the carboxylic end of the polymer at the ester bond [47]. Antheunis et al. (2010) 
explained that the ester bonds of both the inner and outer chains are broken in bulk 
hydrolysis [47]. Polymer hydrolysis can be categorized in two ways, bulk or surface. 




hydrolysis, water penetrates through the surface of the polymer and dissolves the polymer 
at an accelerated rate in comparison [16]. A diagram illustrating the difference between 
the two types of erosions can be seen in Figure 2-2. In each case, it is the ester bond that 
is cleaved that facilitates polymer degradation. However, the breaking of the ester bonds 
is innately unpredictable yet somewhat proximal.    
 
Figure 2-2: Illustration of the difference between bulk and surface erosion due to 
polymer hydrolysis.  
Biodegradable polymers can further be divided into the two sub-categories of 
bioresorbable and non-bioresorbable. The distinction between the two is such that 
bioresorbable materials are classified as having the potential to partially or entirely be 
absorbed by cells and be utilized [48]. Several different analysis tests can determine the 
hydrolysis of the bioresorbable polymer. Some of these tests include lactic acid release 
testing, thermal property analysis and monitoring the decrease in molecular weight, all of 
which would be done with an in vitro analysis before the implant was approved for in 




starting molecular weight [49]. Higher molecular weight polymers tend to withstand 
degradation longer than lower molecular weight polymers of the same material. 
Due to the high molecular weight and machinability of poly-glycolic acid (PGA), 
it is the ideal polymer to use to manufacture bioresorbable implants such as sutures. 
Sutures made of PGA lose most of their mechanical properties, such as strength, in as 
few as 2-4 weeks post-implantation [50]. However, when PGA is not combined with 
other polymers, it tends to have a rapid degradation. Polylactic acid (PLA) is weaker in 
comparison but has a slower rate of resorption than other readily used polymers such as 
PGA [51]. PLA may be a better polymer than PGA as a stand-alone polymer when 
considering bioresorbable thermoplastics for bone mending due to its slower degradation 
rate. Its ability to maintain the original strength of the bone fixation device for a long 
time is the leading rationale behind this conclusion. While PLA undergoes bulk 
hydrolysis, it does so at a slower rate than PGA [16].  
A combination of PGA and PLA would produce a polymer composite to make an 
implant that has the strengths of both polymers. Even this polymer composite is not 
perfect for all implant applications such as sutures, screws, scaffolds and stabilization 
plates. The addition of polycaprolactone (PCL) further increases the strength and function 
of the implant. PCL is a relatively inexpensive biodegradable polymer that has a low 
melting point. PCL is the least rigid of the polymers mentioned above but holds its mass 
in vivo for up to twice as long as the other two polymers [52]. Its ability to resist 
degradation is ushering research in its ability to become a longer-term scaffold that can 




The desired characteristics of multiple polymers can be combined to make a 
thermoplastic superior to their constituents [54]. A nanocomposite can be constructed 
using a blend of various polymers in various ratios to make a polymer blend or 
copolymer. Polymer blends are created of two or more polymers that have been simply 
blended into a filament or solvent cast. A copolymer is similar, but with the addition of a 
polymerizing step that would combine two or more polymers into a new type of 
polymer.  
Post hydrolysis, the polymer is broken down as if it were any other naturally 
occurring substance. PGA hydrolyses into glycine, while PLA hydrolyses into lactic acid 
[55]. The excess glycine is either excreted or converted into glucose to be used later. The 
excretion process for glycine is facilitated through urination. The other pathway to 
eliminate the excess glycine is to convert it into water and carbon dioxide by the citric 
acid cycle [55]. Once PLA is broken down into lactic acid, it is filtered out of the blood 
by the liver or kidneys and expelled in urine. Lactic acid can also be filtered out of the 
blood system by the liver and kidneys, where it follows a pathway to be metabolized by 
the Cori Cycle, which produces glucose. PCL is converted into ꞓ-hydroxy caproic acid, 
filtered out of blood and expelled in urine. PGA will not be used in this study due to the 
inability to secure a supply of unprocessed polymer beads but will be included in future 
experiments. 
2.3 Infill 
The wall thickness, infill pattern and infill density are more important than the 
printing method of a 3D printed model. It is these three principles that will give the 




typically changed to adjust the print time, material consumption, density, and rigidity 
[56]. The three most common infill patterns are the rectangular, concentric and 
honeycomb patterns. Comparison and reliability test printing must be done to determine 
the most favorable infill density and pattern for a given model on a 3D printing machine.  
The CAD file that determines the overall shape of the model while the rendering 
software is responsible for the infill pattern. The default settings of a printer are typically 
predetermined by the printer unless otherwise changed [57]. The combination of the 
CAD file and infill information is generally contained in the g-code file, which 
communicates the internal and external patterns and build plate temperature, printer head 
speed, filament retraction and cooling fan settings. Wall thickness is simply the number 
of solid layers along the parameter of the printed model. The top and bottom layers of a 
model are programmed differently from the wall thickness and can be as few as zero to 







CHAPTER 3  
POLYMER MIXTURE TESTING 
3.1 Introduction 
The blending of biodegradable polymers can enhance their ability to perform 
mechanically [58]. The result of blending polymers can positively affect limitations 
which include brittleness, stiffness, toughness, and rigidity. The strengthened restrictions 
remain even while being enacted upon by outside stimuli such as temperature and 
moisture variations. Mixing PLA and PCL has the effect of harnessing the strengths of 
both individual polymers. The power of PLA and the flexibility of PCL combine to make 
a polymer blend that is rigid enough to resist bending but flexible enough to bend without 
breaking. The amount of flexibility in the polymer blend is directly correlated with the 
amount of PCL within the composite. PCL acts as a plasticizing agent that can increase 
the ability of a nanocomposite to withstand failure through enhanced ductility and 
flexibility when under strain [58].  
Additionally, composites made with both PLA and PCL have displayed a property 
not seen in PLA or PCL in their unblended composites. Navarro et al. explained that the 
shape memory effect is a behavior which involves of the ability to maintain or regain the 
original shapes when acted upon by an outside force or condition [59]. Moreover, the 





phases which have the responsibility to reobtain the original shape or the ability to 
conform to a new form [59]. The process in which the polymers bend and reform is 
known as programming and recovery. The programming and recovery process is 
characterized by the temporary deformation from the original shape and then a 
reformation step back towards the original shape [59]. It is thought that the multiphase 
design is due to the differences in the glass transition of the two polymers.    
Polymer mixing of different percentages have been tested in the past. Typically, 
the blending process is done by mixing the polymers in heated mixer and pressed into a 
mold to cool [60]. The extrusion method is also used, but it is done less often due to the 
special equipment needed and difficulty to produce a uniformed product. Additional 
additives can be added to the polymer mixture to give the finished polymer blend added 
properties. Halloysite are one such material that has been shown to increase a variety of 
physical properties [61][62]. While the position and orientation of the embedded HNTs 
are somewhat unpredictable, their presence show several benefits such as increased 
strength, thermal regulation, flame retardance, and a nanocontainer/carrier.  
 Halloysite nanotubes are naturally occurring, one dimensional nanomaterials that 
resembles a hollow tube. The shape HNTs give them a high aspect ratio. Because of the 
nature of its high aspect ratio, HNTs make great structural reinforcers for polymers. A 
noticeable addition of strength has been documented by the addition of as low as 5% of 
total weight composite material [62]. Polymers can see an increase in stiffness, strength, 
and impact resistance simultaneously with the addition of HNTs [62]. The added 





implants, bone grafts, and bone cements [62]. In conjunction with the benefits listed 
above, halloysite increase the composite’s ability to adhere to bone in in vivo studies [62].  
 The desired concentration of doped HNTs for this experiment was 5% and 10%. 
A single coating using the method below was sufficient to achieve this percentage. A 
double coating method was used to manufacture a polymer blend filament with 10% 
doped HNTs. The methods differ because the outside surface of the polymers became 
saturated with HNTs when coating with 5%, thus any additional HNTs would not coat 
the polymer beads and simply agglomerated onto the mixing container. A higher 
percentage of doped HNTs offer a higher ability to release dopant and possible structural 
strength increase. 
The experiments in this chapter were performed to design parameters to 
manufacture an HNT embedded PLA/PCL blended polymer. The parameters include 
HNT percentage, extrusion of filament temperatures, and polymer combinations. The 
polymer preconditioning was kept constant, but the polymer composition was modified. 
Different ratios of the polymer were tested to determine which would give the best 
physical attributes to the final nanocomposite. The ratios of PLA to PCL were 80:20, 
70:30, 60:40, and 100:0. The 100:0 polymer filament served as a reference to gauge the 
difference in physical strength due to the addition of PCL. In each case, HNTs or silicon 
nitride were embedded into each filament during the extrusion process. After making the 
filament, each iteration of the filament was printed into a testing strip using the same 
coding to ensure consistency. We hypothesize that a polymer blend of 80:20 PLA/PCL 







3.2 Methods and Materials 
3.2.1  Growth Factor Hydration 
Recombinant Human TGF β1, Recombinant Human TGF β3, and Recombinant Human 
BMP2 were purchased from ProSpec (Rehovot, Israel). Recombinant Human TGF β2 
was purchased from TonBo Bioscience (San Diego, US). Each growth factor protein was 
hydrated according to the manufacturer’s specifications. Once hydrated, each respective 
growth factor was diluted to make a 1 µg/ 10 ml solution in phosphate-buffered saline 
(PBS).  
3.2.2   Halloysite Loading 
25 mL of PBS was placed in an autoclaved 100 mL beaker with a stir bar. 25 mL 
of the hydrated growth factor and PBS solution was added to the PBS and stirred for 60 
seconds. 5 g of halloysite nanotubes were slowly added to the beaker containing the 
PBS/GF solution. The solution was stirred for 5 minutes to combine. The beaker was then 
placed into the glass vacuum chamber and a 75 cm Hg vacuum was pulled for 5 minutes 
and released. The vacuum and release were done five times, shaking every minute to 
release trapped air bubbles. A final vacuuming step was taken for an additional 24 hours. 
After the final vacuuming step, any remaining liquid was aliquoted and the doped 
halloysite was dried in an incubator at 30°C for 24 hours. Figure 3-1 shows a visual 








Figure 3-1 Diagram of the loading of halloysite nanotubes process. Red dots = growth 
factors. 
3.2.3   Polymer Preparation 
The PLA used as a source in all blends was purchased from Sigma Aldrich and 
had a molecular weight of 60,000. The PCL for each combination was purchased from 
Aldrich Chemistry and had a molecular weight of 80,000. Each polymer was kept in a 
tightly sealed contain to prevent uptake of water due to humidity.    
3.2.3.1  PLA : Loaded HNTs Coating 
PLA (50g) was added to a 1000 mL beaker and placed into an incubator at 45°C 
for 24 hours. 200 µl of silicone pump oil (SPI Supplies) was pipetted onto the warm 
polymer beads with a P200 micropipette. Parafilm was placed over the beaker’s opening 
and the contents were vortexed then shaken in 60 seconds intervals respectively for a 
total of 6 minutes to thoroughly coat the polymer beads. The coated beads were then 
transferred into a clean 250 mL beaker to prevent access oil from coating the sides of the 
beaker, thus taking away from the coating in the next step. 2.5 g of preloaded halloysite 
nanotubes were added to the oiled polymer beads. Parafilm was place over the beaker. 
The contents were vortexed and then shaken in 60 seconds intervals, respectively, for 6 
minutes to thoroughly coat the polymer beads with the loaded HNTs. The HNT coated 





3.2.3.2  PLA : Silicon Nitride Coating 
PLA (50g) was added to a 1000 mL beaker and placed into an incubator at 45°C 
for 24 hours. 200 µl of silicone pump oil was pipetted onto the warm polymer beads with 
a P200 micropipette. Parafilm was placed over the beaker’s opening and the contents 
were vortexed then shaken in 60 seconds intervals respectively for a total of 6 minutes to 
thoroughly coat the polymer beads. The coated beads were then transferred into a clean 
250 mL beaker. 5 g of silicon nitride was pulverized using a mortar and pestle. 2.5 g of 
the pulverized silicon nitride was added to the oiled polymer beads. Parafilm was place 
over the beaker. The contents were vortexed and then shaken in 60 seconds intervals 
respectively for 6 minutes to thoroughly coat the polymer beads with the silicon nitride. 
The silicon nitride coated polymer beads were placed in a 37°C incubator for 24 hours. 
3.2.3.3   PLA:PCL with Loaded HNTs Coating 
In separate containers, 40 g of PLA and 10 g of PCL, 35 g of PLA and 15 g of 
PCL, and 30 g of PLA and 20 g of PCL was added to a 1000 mL beaker, shaken to 
combine, then placed into an incubator at 40°C for 24 hours. 200 µl of silicone pump oil 
was pipetted onto the warm polymer bead mixture with a P200 micropipette. Parafilm 
was placed over the beaker’s opening and the contents were vortexed then shaken in 60 
seconds intervals respectively for a total of 6 minutes to thoroughly coat the polymer 
beads. The coated beads were then transferred into a clean 250 mL beaker. 2.5 g of 
preloaded halloysite nanotubes were added to the oiled polymer beads. Parafilm was 
place over the beaker. The contents were vortexed then shaken in 60 seconds intervals 
respectively for 6 minutes to thoroughly coat the polymer beads with the loaded HNTs. 





3.2.3.4  PLA:PCL with Silicon Nitride Coating 
In separate containers, 40 g of PLA and 10 g of PCL, 35 g of PLA and 15 g of 
PCL, and 30 g of PLA and 20 g of PCL was added to a 1000 mL beaker, shaken to 
combine, then placed into an incubator at 40°C for 24 hours. 200 µl of silicone pump oil 
was pipetted onto the warm polymer bead mixture with a P200 micropipette. Parafilm 
was placed over the beaker’s opening and the contents were vortexed then shaken in 60 
seconds intervals respectively for a total of 6 minutes to thoroughly coat the polymer 
beads. The coated beads were then transferred into a clean 250 mL beaker. 5 g of silicon 
nitride was pulverized using a mortar and pestle. 2.5 g of the pulverized silicon nitride 
was added to the oiled polymer beads. Parafilm was place over the beaker. The contents 
were vortexed then shaken in 60 seconds intervals, respectively, for 6 minutes to 
thoroughly coat the polymer beads with the silicon nitride. The silicon nitride coated 
polymer beads were placed in a 37°C incubator for 24 hours. 
3.2.3.5  PLA Double Coating 
50 g of PLA was added to a 1000 mL beaker and placed into an incubator at 45°C 
for 24 hours. 200 µl of silicone pump oil was pipetted onto the warm polymer beads with 
a P200 micropipette. Parafilm was placed over the beaker’s opening and the contents 
were vortexed then shaken in 60 seconds intervals respectively for a total of 6 minutes to 
thoroughly coat the polymer beads. The coated beads were then transferred into a clean 
250 mL beaker. 2.5 g of preloaded halloysite nanotubes were added to the oiled polymer 
beads. Parafilm was place over the beaker. The contents were vortexed then shaken in 60 
seconds intervals, respectively, for 6 minutes to thoroughly coat the polymer beads with 





hours. The loaded HNT coated polymer beads were removed from the beaker and placed 
into a clean 250 mL beaker, leaving any access HNTs in the former beaker. 300 µl of 
silicone pump oil was pipetted onto the coated polymer beads with a P1000 micropipette. 
Parafilm was placed over the opening of the beaker. The contents were vortexed then 
shaken in 60 seconds intervals, respectively, for a total of 6 minutes to thoroughly coat 
the precoated polymer beads. The coated beads were then transferred into a clean 250 mL 
beaker. 2.5 g of preloaded halloysite nanotubes were added to the oiled precoated 
polymer beads. Parafilm was place over the beaker and the contents were vortexed then 
shaken in 60 seconds intervals, respectively, for 6 minutes to thoroughly coat the polymer 
beads with the loaded HNTs. The HNT coated polymer beads were placed in a 37°C 
incubator for 24 hours. 
3.2.3.6  80:20 PLA:PCL Double Coating 
40 g of PLA and 10 g of PCL was added to a 1000 mL beaker, shaken to 
combine, then placed into an incubator at 40°C for 24 hours. 200 µl of silicone pump oil 
was pipetted onto the warm polymer bead mixture with a P200 micropipette. Parafilm 
was placed over the opening of the beaker and the contents were vortexed then shaken in 
60 seconds intervals respectively for 6 minutes to thoroughly coat the polymer beads. The 
coated beads were then transferred into a clean 250 mL beaker. 2.5 g of preloaded 
halloysite nanotubes were added to the oiled polymer beads. Parafilm was place over the 
beaker. The contents were vortexed then shaken in 60 seconds intervals, respectively, for 
a total of 6 minutes to thoroughly coat the polymer beads with the loaded HNTs. The 
HNT coated polymer beads were placed in a 37°C incubator for 4 hours. The loaded 





mL beaker, leaving any access HNTs in the former beaker. 300 µl of silicone pump oil 
was pipetted onto the coated polymer beads with a P1000 micropipette. Parafilm was 
placed over the opening of the beaker. The contents were vortexed then shaken in 60 
seconds intervals, respectively, for 6 minutes to thoroughly coat the precoated polymer 
beads. The coated beads were then transferred into a clean 250 mL beaker. 2.5 g of 
preloaded halloysite nanotubes were added to the oiled precoated polymer beads. 
Parafilm was place over the beaker and the contents were vortexed then shaken in 60 
seconds intervals, respectively, for 6 minutes to thoroughly coat the polymer beads with 
the loaded HNTs. The HNT coated polymer beads were placed in a 37°C incubator for 24 
hours. 
3.2.4   Filament Extrusion 
Once the desired polymer blend was coated and heated for 24 hours, it was ready 
to extrude. The drying step must not be skipped to ensure the proper extrusion of the 
polymer beads into a filament with minimal air bubbles and entrapped water. A “Noztek 
Pro Filament Extruder” was used to extrude a 1.75 mm filament with a desired standard 
de of no more than 0.05 mm. There was no feed rate adjuster, so the temperature to 
achieve the specific desired filament thickness differed for every blend and additive. The 
extrusion temperatures are displayed in Table 3-1. To prevent contamination, of air 
bubbles or cleaning solvent from being embedded within the newly made filament, the 
first 5 meters were discarded as per the manufacturer’s instructions. The filament was 
then wound into a spool and placed into a Zip Loc plastic freezing bag and placed into 






3.2.5   Three-Point Bend Tests 
3.2.5.1  Bend Tests 
 Each respective iteration of filament was 3D printed into the shape depicted in 
Figure 3-2. The wall thickness on the print was 3 layers while the top and bottom 
surfaces were 2 layers thick. The shape was created using TinkerCad and the G-code was 
written using Ultimaker Cura 3.5 software. Elasticity test were preformed using a 
CellScale UniVert modulator (Ontario, Canada). Each sample was placed onto the 
Univert testing platform and the middle point was lowered until the load was 0.02 N of 
force. In this test, the middle arm was moved down to 3cm at a speed of 1cm/s and 
retracted at 1 cm/s for a series of 5 bends for each sample. Tests were also done to a 
depth of 5 cm at a speed of 1 mm/s and retracted at 1 cm/s. 
 
Figure 3-2: Rendering of the shape to make the 3D print for the 3-point bend tests. Each 
square represents 1 mm2. The dimensions are 56 mm x 8 mm x 2.5 mm. 
3.2.5.2   Failure Tests 
 Each sample was printed in the same shape as the bend tests. With a similar setup 
as the 3-point bend test, the failure test was performed on the CellScale Univert 
modulator. As before, the sample was placed on the bottom 2 points and the middle 





The break test was performed by moving the middle arm down at a rate of 1cm 
per second until the sample failed. For the safety of the machine, a maximum distance of 
10cm was the programmed stopping point if a failure did not occur. Testing was done on 
non-degraded and degraded samples. The non-degraded samples were subjected to 
testing 1 day after printing. The degraded samples were exposed to PBS for 6 or 12 
weeks at 37°C. During the degradation period, the nanocomposites were vortexed for 10 
seconds every 48 hours. Non-degraded and degraded samples were compared to chart the 
loss of strength due to degradation. 
3.2.6   Nanocomposite Degradation for Bend and Failure Tests 
The nanocomposite was printed using the “Creality Ender 3 Pro” 3D printer into 
the bowtie shape of the bend and failure tests. Once the nanocomposite was printed, it 
was stored in the freezer at -20°C until all nanocomposites were ready to undergo 
degradation. The nanocomposites were then washed with deionized water and placed into 
falcon tubes with 15 mL of PBS and placed into an incubator at 37°C. The samples were 
vortexed every 2 days for a degradation time of 20 weeks.  
3.2.7   Degradation Testing 
 The degradation profiles of each blend of the nanocomposite were also 
investigated. The tests were performed by placing each 3D printed nanocomposite 
composition into separate sample tubes containing 15 mL of PBS at 37°C. Each sample 
was vortexed every 48 h to ensure even degradation. The design was made to more 
closely mimic the outer surface that the nanocomposite would have in vivo once the 
nanocomposite was implanted and held in place as a brace and screw combination. 





hydrolyze the nanocomposite from surfaces that would have been plugged. Figure 3-3 
show the shape of the 3D printed nanocomposite that was degraded for this study. Cells 
prefer a textured surface to attach rather than smooth surface. A textured surface was 
created to aid in cell adhesion. The nanocomposite was dipped in 5M sodium hydroxide 
for 1 minute. Readings of 6 different samples were taken every 4 weeks for a total of 20 
weeks. The NanoDrop 2000c spectrophotometer was used to read the absorbances of the 
released monomer in a quartz cuvette. To monitor the hydrolysis of each polymer over 
the 20 weeks, PLA and PCL were analyzed at 230nm for PLA and 270nm for PCL. PBS 
was used in place of commonly used simulated body fluid (SBF) because of the long 
period of time used to degrade the nanocomposite. SBF needs to be changed periodically 
due to rising pH levels unlike PBS.  
 
Figure 3-3 Rendering of the shape to make the 3D print for the degradation and elution 
tests. Each square represents 1 mm2. The maximum dimensions are 25 mm x 14 mm x 3 
mm. 
3.2.8  Statistical Analysis 
Statistical analysis was performed using Microsoft Excel Analysis ToolPak plugin 
and Origin 9.6. All experiments were done in triplicate and with one-way analysis of variance 





Statistically significant data was reported (p < 0.05), and all the results were reported as mean 
± standard deviation (p < 0.05, n=3) unless otherwise specified.  
3.3 Results and Discussion 
3.3.1   Extrusion Temperature 
 The objective of the first experiment was to determine the optimum temperature 
for extrusion of filaments with 5 or 10% additive addition. Using single and double 
coating methods that distributes additive onto polymer beads, a filament was made using 
the same extruder but at different extrusion temperatures. Table 3-1 shows each 
extrusion temperature and the diameter of each filament.  
Table 3-1 The extrusion temperature and diameter of each filament composition. 
Filament measurements were taken every meter. 30 measurements were taken to 
determine deviation. 
PLA:PCL Additive Temperature Diameter Tolerance 
100:0 HNT 180°C 1.75mm 0.03 
100:0 SiN 170°C 1.75mm 0.02 
100:0 Double HNT 184°C 1.75mm 0.02 
100:0 Double SiN 170°C 1.75mm 0.01 
80:20 HNT 175°C 1.75mm 0.01 
80:20 SiN 172°C 1.75mm 0.02 
70:30 HNT 175°C 1.75mm 0.03 
70:30 SiN 172°C 1.75mm 0.01 
60:40 HNT 174°C 1.75mm 0.02 
60:40 SiN 171°C 1.75mm 0.01 
Although the 1.75 mm filaments were made, the double-coated filament 
containing 10% additive was brittle and noticeable rough once extruded. However, the 
single-coated 5% additive filaments were flexible, and the surface was smooth. For 3D 





experiments due to the filament’s abrasiveness and brittleness. The ability to make 3D 
prints was compromised due to the physical conditions of the manufactured filament. 
Only the filaments with 5% HNT or 5% silicon nitride were used for the duration of the 
later experiments. 
3.3.2   Strength Testing 
3.3.2.1  3-cm Bend 
 Bones are designed to distribute applied mechanical loads; therefore, a brace 
should withstand applied stresses and strain. The 3cm bend test was more of an extreme 
bend than bones typically receive. Each individual blend showed a decrease in strength 
over time with repeated bends. Figure 3-4 show the average of 3 different 
nanocomposites of each polymer blend. The error bars represent the standard deviation of 
each maximum force at 3cm of bend. The slopes of the peaks represent the average loss 
in the amount of force needed to reach a 3cm bend. A more negative slope of the 
trendline represents a higher degree of loss strength. The slope of the 80:20 blend was 
closer to zero, meaning that it showed the least amount of strength lost sue to repeated 
bending. The over lay of the graphs in Figure 3-5 shows that the 80:20 needed similar 









Figure 3-4: The graphs of the force exerted upon the nanocomposites during the 3 cm 3-
point bend test for (A) PLA, (B) 80:20, (C) 70:30, and (D) 60:40 polymer blends. Error 
bars represent the standard deviation of the peaks. (n=3) 
 
Figure 3-5: A composite of the forces exerted onto the nanocomposites during the 3-
point bending test. Each line represents the average of 3 tests.  
 












































































A composite of the force graphs for the 3cm 3-point bend test of the 
nanocomposite is shown in Figure 3-5 demonstrates that with the addition of more PCL, 
less force is needed to reach the maximum bend length of 3cm. The graph represents an 
average of the forces acted upon of 3 samples per polymer blend. The outcome was 
predicted due to the plasticizing nature of PCL. Remarkably, the 80:20 combination 
showed similar strength to the PLA nanocomposite but had less loss of power after 
bending. The elastic effect was seen in all PCL containing nanocomposites. While the 
addition of PCL past 20% showed a decrease in force needed to bend, the 
nanocomposite’s recovery and ability to sustain supplemental stress was heightened. The 
80:20 blend offered the best combination of strength and flexibility with regard to the 3-
point bend test.  
3.3.2.2  5-cm Bend 
 A lack in reflex was observed in each iteration of the nanocomposite following 
the maximum bend distance. The non-linear line of the down slope of the force graph in 
Figure 3-6 illustrates this fact. If an even rebound was observed, there would be less of 
an immediate drop in force. A 3 cm bend is an extreme deformation for a bone, much less 
a fixation plate, but a 5 cm bend was tested to see if the effects of the lag in reformation 








Figure 3-6: A composite of the forces exerted onto the nanocomposites during the 5cm 
3-point bending test. Each line represents the average of 3 tests.  
The 5cm bend test showed a lower ability to reform after an extreme bend, 
regardless of the amount of PCL present in the blend. Similar to the 3 cm bend test, the 
80:20 blend showed identical properties as the PLA nanocomposite. Remarkably, a 
massive overall loss in strength was not observed. The evidence of this is in the force 
peaks. While there is a decrease such as seen in the 3cm bend, it was not as drastic.  
3.3.2.3  Break Tests 
 Complete nanocomposite failure was tested on newly printed nanocomposites and 
nanocomposites degraded for 6 or 12 weeks. The comparison of each respective blend 
concerning degradation is displayed in Figures 3-7, 3-8, and 3-9. In these Figures, each 
dot represents an actual failure, and the lines represent the average forces and distances 
























Figure 3-7: Force (N) to break the nanocomposite after a degradation period of 0 weeks. 
Each line is the average of exerted force. Each dot is the maximum force applied with 
respect to distance before failure. 
 
Figure 3-8: Force (N) to break the nanocomposite after a degradation period of 6 weeks. 
Each line is the average of exerted force. Each dot is the maximum force applied with 



















































Figure 3-9: Force (N) to break the nanocomposite after a degradation period of 12 
weeks. Each line is the average of exerted force. Each dot is the maximum force applied 
with respect to distance before failure.   
The newly printed PLA and 80:20 blend had comparable strength, while the other 
combinations showed that the increase in PCL percentage made the nanocomposite 
weaker. The nanocomposites that were degraded for 6 weeks all showed a large decrease 
in strength except for the 70:30 blend. Due to the unpredictable nature of constructing the 
filament, a small section may have been composed of more PLA than desired. A PCL 
rich surface would have a slower degradation than one that had PLA more towards the 
surface. PLA rich filament sections could allow the nanocomposite to behave more like 
PLA. The nanocomposites that were exposed to PBS for 12 weeks show a much lower 
ability to resist force. It is speculated that the PCL in the blends is becoming either stiff or 
brittle due to the exposure to PBS thus losing their elastic properties. PLA experienced 
























be noted that every PLA nanocomposite had a catastrophic failure in which it was 
completely broken in half. PCL containing nanocomposites remained in a single piece.  
The trend of having a general weakening effect as the percentage of PCL 
increased was once again observed. For a comparison of work needed to cause failure, 
and the standard deviation of each blend, see Figures 3-10, 3-11, and 3-12. 
 
Figure 3-10: Average work needed to destroy the nanocomposite after a degradation 





















Figure 3-11: Average work needed to destroy the nanocomposite after a degradation 
period of 6 weeks. Error bars represent the standard deviation. (n=3) 
 
Figure 3-12: Average work needed to destroy the nanocomposite after a degradation 
































The loss in strength of each respective blend can be seen in Figure 3-13. Each 
point represents the average work needed to break three nanocomposites after 
degradation over the 0-, 6- or 12-week periods. The slope of the trendline illustrates the 
degree of loss of strength and can be seen in the bottom left corner of the graph. As 
before, the more negative the slope of the trend line, the higher the strength loss.  
 
Figure 3-13: Graph of work needed to destroy each blend of nanocomposite after 
degrading for 0-, 6-, and 12-weeks. The slope of each line represents the trendline of each 
nanocomposite. Error bars represent the standard deviation. (n=3 for each point) 
Unlike before, the strength loss was from degradation due to polymer hydrolysis 
did not favor the 80:20 blend. The 80:20 blend showed the least retention of strength after 
degradation, while the nanocomposite without PCL showed the best retention followed 
by the 60:40 blend. Regardless of the trend, the 80:20 blend was one of the top 
performers for each degradation period. The steep slope could be attributed to the higher 
strength of the non-degraded nanocomposite. This observation can be coupled with the 
100:0 y = -0.3274x + 1.7418
80:20 y = -0.5422x + 2.2007
70:30 y = -0.4173x + 1.905


























nanocomposite degrading and becoming as weak as the other nanocomposite blends over 
time due to degradation.   
3.3.3   Degradation Testing 
 Due to the performance of the strength tests, a decision was made to exclude the 
70:30 and 60:40 blends from further tests. A nanocomposite consisting of these two ratios 
would not be able to produce a nanocomposite with enough strength and flexibility to be 
effectively used to fixate bone. Degradation testing was performed on the 80:20 blend to 
chart the hydrolysis of each respective polymer into monomers. PLA was also tested for 
comparison purposes. The absorbance of the lactic acid monomers that resulted from the 
hydrolysis of PLA can be seen in Figure 3-14. Figure 3-15 and Figure 3-16 show the 
absorbances of lactic acid and ꞓ-hydroxy caproic acid in PBS that was formed due to the 
hydrolysis of the 80:20 blend.  
 
Figure 3-14: Absorbance recorded at 230 nm to characterize lactic acid in PBS over a 
































Figure 3-15: Absorbance recorded at 230 nm to characterize lactic acid in PBS over a 
20-week period for the 80:20 blend nanocomposite. Error bars represent standard 
deviation. (n=6) 
 
Figure 3-16: Absorbances recorded at 270 nm to characterize ꞓ-capronic acid in PBS 


















































See Figure 3-17 to properly gauge the total amount of polymer hydrolysis and 
release of monomers from the 80:20 blend. The intensities of absorbance were combined 
to give a comparison to the lactic acid released by the PLA nanocomposite.  
 
Figure 3-17: Absorbance values of the combined ꞓ-capronic and lactic acid in PBS over 
a 20-week period for the 80:20 blend nanocomposite. Error bars represent the combined 
standard deviations. (n=6) 
The amount of monomer in solution for the PLA nanocomposite were higher than 
the monomers released from the 80:20 blend. A comparison can be seen by looking at 
Figures 3-18. PCL is known to undergo hydrolysis at a slower pace when compared to 
PLA, and the results of this degradation study supported that statement. A comparison of 
the slope of each degradation rate further supports that PLA degrades faster that the 































Figure 3-18: Graph showing the values associated with the hydrolysis of each 
nanocomposite. Error bars represent the standard deviation. (n=6) 
3.4 Discussion and Conclusions 
 Our hypothesis was supported by the test performed in the previous experiments. 
PCL has been shown to increase PLA’s flexibility in every test performed in this 
experiment. The elastic gain did not outweigh the strength lost due to the addition of PCL 
past the 20% threshold. A blend of PLA and PCL has similar strength and increased 
flexibility when compared to PLA alone. To manufacture usable filament with additives, 
the amount of additive must be kept to a certain percentage to create a uniform filament, 
suitable for 3D printing. It was found that extruding a filament with 10% HNT or silicon 
nitride negatively affected the filament’s quality, making it unusable for 3D printing 
using our printers.   
 The amount of monomer in solution supports the expected behavior of the 
hydrolysis process of each polymer. PLA dissolves at a much faster rate than PLC. We 
























extruded into a single filament. The combined monomer in the solution of the 80:20 
blend at 20 weeks of degradation was similar to the amount of monomer released into the 
solution of the 100:0 polymer after 12 weeks of degradation. A slower degradation gives 
the nanocomposite an ability to stabilize the fracture for a longer period while new bone 
is being formed. The additional time can increase thickness of bone due to a prolonged 
exposure to the growth factors that are eluted from the nanocomposite. We suspect that if 
the nanocomposites with higher levels of had been tested in parallel for degradation rate, 
it would have had a slower rate than the 80:20 blend.  
Future studies will be conducted with the addition of PGA to further fine-tune the 
nanocomposite’s strength, flexibility and degradation for a specified time length. The 
current problem of a readily available supply of PGA continues to exist. To further refine 
the nanocomposite, similar tests can be performed with PLA and PCL ratios that are 
close to the 80:20 blend that had the best outcome of the blends tested in this experiment. 
The ratios of interest for future studies of PLA:PCL:PGA are 80:15:5, 80:10:10, 75:20:5, 
70:20:10 and 75:15:10, respectively. Moreover, an additional test can be performed to 
evaluate a condition that was not tested in this set of experiments, torque. The 
nanocomposite could be expected to resist rotational force due to normal bodily 
movements. An examination of the force needed to rotate the nanocomposite by a certain 
degree could be warranted. The amount of rebound to return to the original shape after 
torque is applied. Lastly, the rotation torque needed for the nanocomposite to fail would 
be tested. These torque tests can be performed on PLA, the 80:20 blend as well as any 






CHAPTER 4  
CELL CULTURE STUDIES 
4.1 Introduction 
 Intercellular communication between cells and their environment can be enabled 
by cellular adhesion [63]. Leyva-Leyva et al. (2015) linked cell adhesion achieved 
throughout focal adhesions and osteogenic differentiation via adhesion components using 
CD105+ and CD105- human mesenchymal stem cells [63]. CD105 is also known as 
Endoglin, a cell surface glycoprotein that is part of the TGF beta receptor complex [64].  
Smad2 signaling due to Endoglin expression has lead synovium-derived mesenchymal 
stem cells to undergo chondrogenesis [65]. Several pathways, such as Wnt, MAPK, 
Smad2/3, and β-catenin, have been researched as signaling pathways that promote 
chondrogenesis or osteogenesis in conjunction with members of the TGF beta super 
family [66].    
 Cellular attachment and exposure to the specific growth factors used in this 
experiment were analyzed for the ability to foster the growth of osteoblasts and 
chondroblasts. Alizarin Red S staining and cell viability/cytotoxicity assays were used at 
predetermined intervals of exposure to the nanocomposites that were eluting the growth 
factors, to analyze cells. Initial testing was done on the nanocomposites to determine the 





of the released growth factor gave insight into the amount of growth factor expected to be 
released and exposed to the stem cells during the cell culture studies.  
 Meinel et al. (2004) observed that MSCs exhibited calcium deposits, which 
increased over time, starting 3 weeks after culturing began. It was noted that the between 
weeks 2 and 3 of the culture, an increase in cell cluster sizes and intensity of staining 
indicating higher calcium deposits was observed suggested the initiation of bone 
formation [64].    
 We hypothesized that our nanocomposite would release growth factor or silicon 
nitride over time and be non-cytotoxic to mesenchymal stem cells while promoting 
osteogenic differentiation. The release of the morphogenic agent contained within the 
polymer nanocomposites have been proven to foster cell proliferation, migration and 
differentiation due to direct exposure.   
4.2 Methods 
4.2.1  FITC/BSA Release Study 
 The release characteristics for the 3D printed nanocomposite were tested using 
FITC tagged bovine serum albumen (FITC/BSA) as a surrogate for growth factors. 
FITC/BSA is less expensive and quantitative analysis upon using a spectrophotometer is 
simple and straightforward. HNTs were loaded with FITC/BSA and 3D printed in the 
same manner as the growth factor containing HNTs. The FITC/BSA/PLA filament was 
3D printed into the dog bone shape as described in chapter 3’s degradation testing using 







4.2.1.1  Making FITC/BSA Filament 
A solution of 10 µg/mL of FITC/BSA in PBS was prepared. Halloysite nanotubes 
(5 g) were slowly added to a 100 mL beaker containing the FITC/BSA/PBS solution. The 
solution was stirred for 5 minutes to combine. The beaker was then placed into a glass 
vacuum chamber and a 75 cm Hg vacuum was pulled for 5 minutes and released. The 
vacuum and release were repeated 5 times, shaking every minute to release trapped air 
bubbles. A final vacuuming step performed for an additional 24 hours. After the final 
vacuuming step, any left-over liquid was aliquoted and washed 3 times with PBS to 
remove any FITC/BSA that remained on the surface. The doped halloysite was then dried 
in an incubator at 30°C for 24 hours.    
PLA (50 g) was added to a 1000 mL beaker and placed into an incubator at 45°C 
for 24 hours. 200 µl of silicone pump oil (SPI Supplies) was pipetted onto the warm 
polymer beads. Parafilm was placed over the opening of the beaker and the contents were 
vortexed then shaken in 60 seconds intervals respectively for a total of 6 minutes to 
thoroughly coat the polymer beads. The coated beads were then transferred into a clean 
250 mL beaker to prevent access oil from coating the sides of the beaker, thus taking 
away from the coating in the next step. FITC/BSA doped halloysite nanotubes (2.5 g) 
were added to the oiled polymer beads. Parafilm was place over the beaker and the 
contents were vortexed and shaken in 60 seconds intervals respectively for a total of 6 
minutes to thoroughly coat the polymer beads with the FITC/BSA doped HNTs. The 
HNT coated polymer beads were placed in a 37°C incubator for 24 hours. A 1.75 mm 






4.2.1.2  Nanocomposite Elution  
The FITC/BSA elution tests were performed by placing each 3D printed 
nanocomposite discs into separate sample tubes containing 2 mL of PBS at 37°C. Each 
sample was vortexed every 48h to ensure even degradation. The design was made to 
more closely mimic the outer surface that the nanocomposite would have in vitro once 
the nanocomposite was glued to a well of a 48 well cell culture plate. Cells prefer a 
textured surface to attach rather than smooth. To mimic the conditioning that the 
nanocomposite would be subjected to as a way of aiding in cell adhesion, the 
nanocomposite surface was slightly degraded to add texture. The nanocomposite was 
dipped in 5M sodium hydroxide for 1 minute. Each nanocomposite was washed with 
water and dried before degradation. 
4.2.1.3   FITC/BSA Concentration Collection 
 Forty-two 3D printed nanocomposites were degraded as described in the previous 
section. Measurements were taken every 4 days from 6 different samples for a total of 4 
weeks. Samples were vortexed for 10 seconds prior to collection. After 2 mL of eluted 
FITC/BSA in PBS was collected and, the sample discarded. The sample liquid was 
analyzed within one hour after collection to prevent FITC/BSA degradation due to light 
interaction.    
4.2.1.4  FITC/BSA Calibration Curve 
 A calibration curve was made using FITC/BSA and PBS. 1 mg of FITC/BSA was 
added to 100 mL of PBS and mixed well to combine to get same amount of FITC/BSA 
that was in solution that was used for vacuum loading HNTs. Further dilutions from the 





dilutions was made and measured from a concentration of 10 µg/mL down to 15.6 ng/mL 
using the Nanodrop 200c spectrophotometer. The results are displayed on Figure 4-1.  
4.2.2   Cell Culture Media 
 Cell culture media was designed to give adequate nutrients to stem cells to 
support proliferation and future differentiation. 400 mL of Dulbecco’s Modification of 
Eagle’s Medium (DMEM) (Corning) with 4.5 g/L glucose, L-glutamine and sodium 
pyruvate was added to a sterile flask. 47.5 mL of fetal bovine serum (FBS)(Biowest) was 
then added to the DMEM. 2.5 mL of penicillin streptomycin solution (Corning) was the 
last media ingredient added to the flask prior to vacuum filtration to remove any large 
particles or contaminants. The solution was labeled “complete media” and placed into the 
refrigerator for storage.   
4.2.3   Cell Culture Proliferation 
 StemPro human adipose derived stem cells were used as a cell source for this 
study. The initial cell plating was done on a ThermoFisher T-75 culture flask placed into 
a 37°C incubator with 5% CO2. Once the confluency was between 90-95%, the cells were 
passaged for further proliferation. Depleted media was removed, 1 mL of 0.25% trypsin-
EDTA was added to the flask and place into the incubator for 75 seconds. The flask was 
then gently tapped to detach any cells that remained attached to the flask. 10 mL of media 
was added to the flask and mixed to suspend the cells throughout the media. 1 mL of the 
cell and media mixture was added to a new culture flask. An additional 9 mL of media 







4.2.4   Nanocomposite Printing and Preconditioning 
 Each nanocomposite iteration was printed using the Creality Ender 3 printer. The 
discs had 50% infill and were cylindrical in shape. Before attaching them to the base of a 
48 well plate, each nanocomposite was preconditioned by dipping them in 5M sodium 
hydroxide for 1 minute. Post preconditioning, the nanocomposites were washed with 
water thrice and dried. Each nanocomposite was plated into individual wells of a 48 well 
plate and secured with superglue. The superglue was allowed to cure for 2 hours before 
the plates containing the nanocomposites was placed under UV light for 30 minutes to 
kill any bacteria that may have landed on the surface.  
4.2.5   Addition of Cells 48 Well Plate 
 Media was removed from each cell culture flask and discarded. 1 mL of 0.25% 
trypsin-EDTA was added to each flask and placed in the incubator for 75 seconds. After 
gently taping the flask to remove any adhered cells, 10 mL of media was added to each 
flask. The contents of all flasks were added to a single flask. The approximate number of 
cells was calculated using the Nexcelom Bioscience Auto T4 Cellometer cell counter. 
The flask containing the cells was diluted to have a concentration of 1 x 106 cells per mL. 
1 mL of the stem cell/media mixture was added to each well that contained a 
nanocomposite and 3 additional empty wells as a control. The media was changed for 
each well every 48 hours.  
4.2.6   Live/Dead Staining 
 Cell viability was tested using the Biotium viability/cytotoxicity assay kit. The 
staining solution was made by adding 1.25 µl of 4 mM calcein AM and 5 µl of 2 mM 





was washed twice with PBS. 300 µl of the staining solution was added to each well and 
allowed to absorb for 1 hour at room temperature in a dark enclosure. Live cells 
fluoresced at 517 nm and dead cells fluoresced at 625 nm. A microscope with filters to 
allow specific excitation wave lengths of 494 nm and 532 nm was used.  
4.2.7   Alizarin Red S Staining 
Alizarin Red S staining was done on a plate of samples at an interval of 1, 7, 14, 
22, 28, and 35 days. Each well of cells were stained with Alizarin Red S stain to 
determine if the cells were calcium-rich, indicating that the stem cells are beginning to or 
have already become pre-osteoblast or pre-chondroblasts. A 40 mM Alizarin Red S 
staining kit was purchased from Sigma-Aldrich. The pH of the alizarin red s was adjusted 
to 4.2 before use with the 10% ammonium hydroxide or 10% acetic acid included with 
the kit. Media was removed from each well and 300 µl of 10% formaldehyde was added 
to each well to fix the cells for 10 minutes at room temperature. The formaldehyde was 
removed, and the well was washed with 500 µl PBS twice to remove as much 
formaldehyde as possible. 250 µl of alizarin red s was added to each well and allowed to 
stain for 15 minutes at room temperature. The final step was to wash the well with water 












4.3.1   FITC/BSA Calibration Curve 
 
Figure 4-1: Graph of the calibration curve of FITC/BSA in PBS to determine the amount 
of FITC/BSA released from the nanocomposite over time. 
4.3.2   FITC/BSA Released into Solution 
 
Figure 4-2: Graph of FITC/BSA released from cylindrical nanocomposites after 
degradation. Error bars represent ± standard deviation. (n=6) 
 

















































Figure 4-3: FITC/BSA released into solution after nanocomposite degradation over 4-
weeks. (n=6) 
4.3.3   Live/Dead Staining 
 
Figure 4-4 Live dead assay of the control wells showing the live cells in green on top 






























                            
    
    
       






Figure 4-5: Live dead assay of wells containing HNT\PLA discs showing the live cells in 
green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and 28. 
 
Figure 4-6: Live dead assay of wells containing TGFβ1\PLA discs showing the live cells 
in green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and 
28. 
 
   
                            
    
    
                            
      
                            
    
    






Figure 4-7: Live dead assay of wells containing TGFβ2\PLA discs showing the live cells 
in green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and 
28. 
 
Figure 4-8: Live dead assay of wells containing TGFβ3\PLA discs showing the live cells 
in green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and 
28. 
  
      
                            
    
    
                            
      
                            
    
    






Figure 4-9: Live dead assay of wells containing BMP2\PLA discs showing the live cells 
in green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and 
28. 
 
Figure 4-10: Live dead assay of wells containing silicon nitride\PLA discs showing the 
live cells in green on top image and dead cells in red on the image below for day 1, 7, 14, 
21, and 28. 
 
    
                            
    
    
                            
               
                            
    
    






Figure 4-11: Graph showing the quantitative values of cell count calculated  
((live - dead) / live). Error bars are standard deviation where n=3. 
4.3.4   Alizarin Red S Staining 
 
Figure 4-12: Alizarin Red S staining of each well after days 1, 7, 14, 21, and 28 days of 
































     
                 
      
      
      
     






Figure 4-13: Alizarin Red S staining of each well after 35 days of exposure to 
nanocomposite.  
4.4 Discussion and Conclusions 
4.4.1.   FITC/BSA Release 
 In this experiment, human mesenchymal stem cells were exposed to PLA 
nanocomposite containing HNTs doped with various growth factors. Preliminary results 
on the 3D printed nanocomposites doped with FITC/BSA showed consistent results for 
the 6 samples that were tested for each period of degradation. Analysis of the release of 
the FITC/BSA contained within the printed nanocomposite revealed a release pattern that 
showed an initial slow release and increased as the polymer began to undergo hydrolysis. 
To calculate the FITC/BSA released into the PBS, the slope of the line in the calibration 
curve was used and the number was doubled to account for the sample size of 2 mL. 
Figure 4-3 shows the total amount of FITC/BSA released into solution. Growth factor 
               





release should follow the same pattern of release due to the similar size and external 
charges of BSA and the growth factor proteins.   
4.4.2   Live/Dead 
 Live dead staining was performed on all samples to reveal the nanocomposite’s 
cytotoxic effects on the stem cells. The results revealed that not only were the 
nanocomposites non-cytotoxic, but they were also a desirable location for cell growth. 
Clustering and cell migration at or near the edge of the nanocomposite made this 
conclusion evident. It is believed that the release of growth factor facilitated the 
agglomeration of cells near the nanocomposite. There was no major decline in the ratio of 
live to dead cells over the entirety of the 28-day cytotoxicity study. The results were 
expected since none of the additives nor the polymers were found to be cytotoxic in tests 
performed on the individual components. In vitro cytotoxicity testing using mesenchymal 
stem cells give confidence that future test using animal models for in vivo testing would 
exhibit similar noncytotoxic effects.   
4.4.3   Alizarin Red S Staining 
 The Alizarin Red S staining was performed in on the cells of all wells including 
the control cells. Although the nanocomposites were predegraded with sodium hydroxide 
to add texture, no further preconditioning was done. A small quantity of growth factor 
was released into solution over the first 4 weeks of the test, thus there was not much 
differentiation in the stem cells. Additionally, research has shown that differentiation into 
the lineage of osteocytes typically shows calcium deposits only after 28 days. The minute 
quantity of growth factor that was released aided in cell recruitment, which was evident 





was planned to be concluded after day 28, however, an additional plate remained and was 
allowed to proliferate and differentiate for an additional 7 days to see post-28-day 
calcium deposits. Contamination was present in all 3 undoped HNT/PLA nanocomposite 
wells for the day 35 reading, so images of those sample were unattainable. The wells that 
contained TGFβ1, TGFβ2, TGFβ3, BMP2, and silicon nitride all had cells that had 
elevated levels of calcium deposits, indicating that cells were differentiating into 
osteocytes or chondrocytes.   
Our hypothesis was supported with the evidence provided by the live/dead and 
Alizarin Red S staining assays. Our nanocomposites released growth factor or silicon 
nitride over time and were seen to be non-cytotoxic to mesenchymal stem cells while 
promoting osteogenic differentiation. The release of the morphogenic agent contained 
within the polymer nanocomposites have been proven to foster cell proliferation, 
migration, and differentiation due to direct exposure.    
4.5 Future Studies 
  Additional testing will be done on nanocomposites of the same material that have 
undergone more significant hydrolysis. A higher degree of degradation has multiple 
effects on cell morphology and structure. Cells may be able to integrate into a 
nanocomposite and grow in 3 dimensions. Additionally, a steady supply of growth factor 
will be available to continue the signaling cascade that would lead to osteogenic 
differentiation. The present study tested the ability of each growth factor to facilitate cell 
migration and differentiation individually. Future research will combine growth factors to 





 Additional western blot testing will be used to specifically confirm the presence 
of ALP++, osterix ++, or osteopontin which are proteins that are produced by immature 
osteoblasts. Epiphycan (Epyc) and unique cartilage matrix-associated protein (Ucma) are 








ANTIBACTERIAL 3D FILAMENT  
AND MASK FILTER 
5.1 Introduction 
The spread of bacteria and viruses can be facilitated through touch or airborne 
contact. Infectious diseases or complications with preexisting ailments may result from 
exposure to these pathogens. Infectious diseases are a leading cause of mortality 
worldwide, with viruses making a significant global impact on healthcare and socio-
economic development. Currently, COVID-19 is a worldwide health pandemic that 
affects the world similarly to the 1918 influenza pandemic that claimed an estimated 
50,000,000 lives. The recent onslaught of the COVID-19 epidemic, caused by a novel 
coronavirus, has affected every facet of human life in some way. Densely populated 
buildings such as prisons, assisted living homes, and hospitals reported thousands of 
cases [67]. The COVID-19 pandemic has caused severe disruptions to human 
communities in employment, medical supplies, household supplies, food and food 
services, mental health, and many more. Life will be different for the foreseeable future 
in these uncertain times. 
The human mouth and nose act as a susceptible environment for viral entry and 





infection for the SARS-CoV-2 virus [69]. Investigations into the expression of the cell 
surface enzyme angiotensin-converting enzyme 2 (ACE2) have been conducted, showing 
binding to a SARS-CoV-2 spike protein [69]. The combination of ACE2 and the spike 
proteins promote the virus’s internalization into human cells [69]. The presence of virus 
binding receptor ACE2 expressed by the mouth and throat epithelial cells makes the virus 
binding challenging to prevent [70], [71]. The spike protein on the surface of 
coronaviruses multifunctional molecular machine mediates coronavirus entry into host 
cells [72]. It first binds to a receptor on the host cell surface through its S1 subunit and 
then fuses viral and host membranes through its S2 subunit. Two domains in S1 from 
different coronaviruses recognize various of host receptors, leading to the viral 
attachment [72]. Recent research has shown evolutionary advantages of the virus in 
binding to the host surface, longer-lasting, and increased active receptor sites in humans 
[73], [74]. 
The transmission of COVID-19 is thought to occur through respiratory droplets. 
Current CDC guidelines recommend using N95 masks for health care providers 
managing the care of patients infected with SARS-CoV-2 or persons under investigation 
(PUI) for COVID-19 [75], [76]. Recent studies have revealed that the aerosolization of 
SARS-CoV-2 is detectable in the air, and the virus remains viable for up to 3 hours [67]. 
The global shortage of PPE in the setting of a viral pandemic has created potentially 
dangerous conditions for frontline healthcare workers lacking appropriate protection and 
their patients [77]. In the spring of 2020, there existed a shortage of N95 masks, surgical 





19 patients. Medical responders need to be protected from respiratory droplets from 
coughing and sneezing in a stressful and intense hospital setting [78].  
COVID-19 particles range from 60-140 nm, while N95 masks filter particles at 
300 nm and only 95 percent of test particles. N99 respirators filter particles at 100 nm, 
and without inactivating pathogen particles. Any smaller particles that are filtered by the 
N95 or N99 mask is done so by electrostatic forces. Additionally, the respiratory droplets 
that are thought to carry the viral particles are larger than the size of the viral particles 
themselves and may also be caught by current masks. However, individuals with chronic 
respiratory, cardiac, or other medical conditions may have difficulties wearing N95 
masks for extended periods due to labored breathing. Due to the high similarities of 
previous novel coronaviruses, it is believed that immunocompromised individuals, 
elderly, and patients suffering from chronic or acute respiratory illness remain highly 
susceptible to the onset of symptoms and higher mortality rates among the general public 
[79], [80]. The virus’s virulent nature remains a threat to all of society as all age groups 
have been impacted in some capacity. Moreover, N95 respirators are not designed for 
children or individuals with facial hair. Because of these inherent gaps in capability, a 
new mask must be developed for increased protection against viral pathogens while also 
taking other considerations into hand such as comfortability and mask related health risks 
and prevention. 
The need for advanced protective masks continues to mount each day for 
healthcare professionals worldwide, with no signs of stopping, even with the control of 
the current COVID-19 pandemic. Because the future timing of outbreaks is unknown, 





remains a high priority. All healthcare personnel, ordinary citizens, and our servicemen 
and their families should not have to resort to homemade apparatus that are potentially 
leaving them at risk to inhale pathogens and are not entirely effective at preventing the 
spread of viral particles [81]. Even though many individuals and groups are designing 
and manufacturing face shield frames for these responders using personal 3D printing 
machines, many designs are not implemented for high-density optimized additive 
manufacturing and cannot be accessed locally [81], [82].  
N95 respirators are personal protective equipment that is used to protect the 
wearer from airborne particles and liquid. An N95 respirator is a respiratory protective 
device designed to achieve a very close facial fit and very efficient airborne particles’ 
filtration. Some N95 respirators are intended for use in a health care setting and worn by 
health care personnel during procedures to protect both the patient and health care 
personnel from the transfer of microorganisms, body fluids, and particulate material as 
well as filtering specific amounts of viruses or bacteria, reducing the amount of but not 
actively killing viruses, bacteria, or fungi [83]–[86]. A recent publication noted co-
infection with other respiratory pathogens was as high as 21% [87]. Surgical masks are 
designed to prevent others from becoming infected due to airborne particles and liquids 
expelled from the wearer. There is a common misconception that surgical masks provide 
adequate wearer protection from the inhalation of harmful microorganisms. Surgical 
masks are used to protect a patients’ wounds from aerosol or mucosal droplets that may 
contain harmful microorganisms and offer little respiratory protection for the user [88].  
The respiratory system is not the sole means of infection by COVID-19 or other 





transferring to the skin from a surface and into the body through any orifice or lesion. 
Research has shown that the attachment of bacteria to horizontal surfaces may stimulate 
bacterial growth [89]. This is due to the increased nutrient deposits as organic material 
tends to settle on its surface [89]. Additionally, metabolites and co-factors may be 
obtained from these surfaces and can lead to biofilms, which protect the bacteria. 
Biofilms provide resistance to mechanical damage, dislodgement due to liquid or airflow, 
and antibiotic treatment resistance [89], [90]. Care must be taken to prevent bacteria from 
producing exopolysaccharide matrix or glycocalyx which are critical components of 
biofilms. A substance that can kill or disable pathogens in a short period is crucial to 
fighting bacterial, fungal, and viral infections.  
The interaction of metal nanoparticles (mNPs) with microorganisms offer many 
advantages for therapeutic applications. The unique physical properties of mNPs have 
associated benefits for drug delivery [91]. These are predominantly due to the particle 
size (which affects bioavailability and circulation time), large surface area to volume 
ratio (enhanced solubility compared to larger particles), the particle’s tunable surface 
charge with the possibility of encapsulation, and excessive drug payloads that can be 
accommodated [92], [93]. Metals such as silver and copper exert toxicity at inherently 
low concentrations that are non-toxic to mammalian cells [94]. It is believed that copper 
kills bacteria by releasing copper cations and reactive oxygen species that disrupt cellular 
activity [95]. The ability to cross bacteria cell membrane and damage vital enzymes are 
the properties that make copper nanoparticles an effective antibacterial material. 
Research has shown that silver nanoparticles damage the bacteria’s outer membrane by 





mechanism is not fully understood, but they have been shown to cause morphological 
changes, membrane leakage and an increase in oxidative stress gene expression [96].    
When mNPs particle size is reduced, this amplifies the toxicity even at low levels 
and increases their prokaryotes’ effects [93]. Combinations of silver, copper, and zinc 
nanoparticles exhibit synergistic antimicrobial activity, which can be attributed to 
increased prokaryotic cell permeability [94]. Furthermore, when mNPs are combined 
with antibiotics and doped into polymers, they have shown a similar augmented 
antimicrobial effect [94], [97].   
In response to the COVID-19 pandemic, we designed an antimicrobial filter and 
mask tandem filtration unit made of medical-grade bioplastics and metal/ceramic 
nanoparticle composites. The filter utilized in our design aimed to possess a porosity of 
50nm due to the nature of the electrospun fibers that form a “spider-web-like” material 
that is breathable and long-lasting. The filter material is similar to the mask’s material 
except for the quantity of mHNTs and manufacturing method. Our first application of this 
filter system was as a replacement to N95 respirators. Critical in our design concept was 
to fabricate a fluid resistant filter unit that provides the wearer protection against large 
droplets, splashes, or sprays of bodily or other hazardous fluids. It also protects the 
patient from the wearer’s respiratory emissions and reduces the wearer’s exposure to 









5.2 Materials and Methods 
5.2.1   Fabrication Design 
The filtration units were fabricated in a variety of sizes with rigid or elastic 
thermoplastics. Polylactic acid (PLA) and thermal plastic urethane (TPU) were the 
polymers of choice to manufacture the filtration unit’s mask portion. PLA was the only 
thermoplastic used for the filter systems. Filters are composed of a commercially 
available gauze, thermoplastic, and mHNTs. We have a patented method for metalizing 
the HNT surface with antimicrobial metals (copper, silver, zinc, and others). 3D printing 
will assemble the masks in a layer-by-layer fashion. It affords a significant ability for 
customization with different metal-coated HNTs (mHNTs), antimicrobial-loaded HNTs, 
and antimicrobial-loaded mHNTs. The filters also carry an electrostatic charge to attract 
small enough particles enough to pass through the filter’s pores.  
5.2.2   Inner and Outer Fabric Layers of the Filter 
Many N95 masks utilize a triple-ply approach to manufacture their respirators. 
These three-ply materials are typically made of an outer layer of bonded fabric, a 
filtration layer comprised of melt-blown material, and an inner layer made of more 
bonded fabric. A similar approach was taken for the manufacturing of the filters for this 
experiment. The filter for the mask was also comprised of three layers. The first and last 
layers were composed of rayon/polyester wound gauze pads (Equate, Bentonville, Ar.). 
The inner layer was comprised of blow-spun PLA/mHNT. A multilayered approach to 
manufacturing the filters offers an improved ability to filter particles in both airflow 





double thick to add more filtering capability by coating both gauze pieces with blow-spun 
material.      
5.2.3   Material Preparation and Filament Extrusion 
5.2.3.1  Metal HNT Preparation 
A non-sacrificial standard two-electrode electrolysis setup was assembled 
consisting of two platinum-coated titanium mesh electrodes acting as a reversible cathode 
and anode.  The electrodes were gently cleaned using silicon carbide abrasive papers and 
ultrasonicated in distilled water for 10 minutes to remove any surface contamination. The 
electrodes were held parallel at a 2-inch distance and connected to a DC power source 
(VWR Accupower 500 electrophoresis power supply). 
An ultrasonicated colloidal solution of 700 mL of 5mM (AgNO3, CuSO4 or 
ZnSO4 respectively) and 350 mg HNT were dispersed in the electrolysis vessel (1000 mL 
VWR borosilicate glass beaker) and continuously stirred using a magnetic stir bar to 
reduce electrophoretic buildup and precipitate formation at the working electrode. A 
temperature of 85°C during the duration of the electrolysis process. The 20V charge was 
applied in 5-minute intervals, after which the polarity was reversed. This process 
continued for a total of six 5-minute cycles for a total of 30 minutes.   
The supernatant was decanted and washed with deionized water three times. The 
solution was centrifuged at 2000 rpm for 5min with water to separate mHNTs from the 
unreacted NPs. The supernatant was removed. The unreacted NPs collect on top of the 
dense pellet after centrifugation and were removed. The mHNTs were then dried at 37°C. 






Figure 5-1: Schematic of the halloysite metal coating process. 
5.2.3.2   HNT and mHNT PLA Filament Preparation 
 Five compositions were tested in this study: PLA, PLA+mHNTs/Zn, 
PLA+mHNTs/Cu, PLA+mHNTs/Ag, and PLA+mHNTs/(Ag,Cu,Zn). Filaments were 
extruded using a Noztek Pro Extruder (West Sussex, England) with a uniform diameter of 
1.75 ±0.05mm, but there was a slightly different filament preparation for each group. For 
the PLA group, PLA filaments were extruded at 175°C. For PLA+mHNTs groups, to 
archive a uniform distribution of HNTs in PLA, 20µL of PEG 200 was added into 20g 
PLA and vortexed for 10 minutes, then 1g of Zn, Cu, or Ag mHNTs were added and 
continually vortexed for another 10 minutes. For PLA+mHNTs/(Ag,Cu,Zn) mixture, 
0.33g of each respective mHNT type were combined before adding them to the PEG 
coated PLA. All mixtures of PLA+mHNTs were extruded at 181°C. Prior to extrusion, 
all compositions were allowed to pre-dry for 4hrs in an incubator at 60°C as per the 





5.2.4   3D Printing of Masks 
 3D printing of the masks was done on an Ender 3 (Shenzhen, China) 3D printer with 
most of the general settings. The mask’s design was produced using the free computer-
aided design (CAD) website TinkerCAD.com and converted to a stereolithography (.stl) 
file. Ultimaker Cura 4.5 was used to adjust design parameters and create the g-code. Each 
mask was printed 205°C with an infill ratio of 50 % and the print platform heated to 50°C 
to aid in bed adhesion.  
5.2.5   3D printing of Testing Discs 
 Each filament was printed into test discs for bacterial studies using a Creality ENDER 
3 Pro (Shenzhen, China) 3D printer with similar settings. Due to the addition of the 
mHNTs, a slightly higher temperature was needed to print the testing discs successfully. 
PLA filament was printed at 205°C, while the PLA/mHNT filament was printed at 
210°C. The test discs were cylindrical, with a height of 2mm and a diameter of 6mm for 
an overall surface area of 94.25mm2. The infill ratio of the discs was 100% to make a 
solid disc with minimal porosity.   
5.2.6   Antibacterial Testing 
 Bacterial cultures were prepared to test the pre-extruded and 3D printed filament’s 
ability to inhibit bacterial growth. Antibacterial testing was done on both GS doped 
mHNTs and undoped mHNTs. The pre-extruded non-doped and doped mHNTs were 
subjected to Mueller-Hinton broth testing. Muller-Hinton agar plates and Muller-Hinton 
broth test tubes were used to provide testing mediums for the antibacterial capabilities of 
the printed non-doped and doped mHNTs. Gentamicin reference discs were plated to give 





5.2.6.1  Muller-Hinton Broth 
 Liquid medium testing was facilitated using Mueller-Hinton broth. 5 mL of Muller-
Hinton broth was added to each glass test tube and autoclaved. Once the broth cooled 
overnight, samples were marked for each polymer sample. We used E. coli and S. aureus 
as a model gram-negative and gram-positive bacterial source. Testing was performed on 
mHNT coated PLA beads, gentamicin doped mHNTs coated PLA beads, 3D printed non-
doped mHNT PLA discs. Finally, 3D printed gentamicin doped mHNTs PLA discs. 
Glass culture tubes were inoculated with 50 µL of E. coli or S. aureus after each 
respective mHNT or doped mHNT bead or disc was added to the broth of each tube. 
Controls of uninoculated Muller-Hinton broth and inoculated broth were used. The 
cultures and controls were incubated at 37°C for 48 hrs. Optical density for the non-
doped mHNT coated PLA beads readings were taken for at the 0 and 48 hr marks. 
Readings were taken for the GS doped mHNTs beads and discs at the 0, 24, and 48 hr 
mark. Each test was done in triplicate and the results were averaged.  
5.2.6.2  Muller-Hinton Agar 
 Muller-Hinton agar plates were prepared for manufacturers’ specifications. We used 
E. coli and S. aureus as gram-negative and gram-positive bacterial sources. Testing was 
performed on 3D printed gentamicin doped mHNTs PLA discs. Each respective filament 
blend was printed into the small cylindrical disc described above. Each polymer was 
plated added to the bacteria covered agar plates before a 24 hr incubation at 37°C. zone 
of inhibition measurements was taken using a digital caliper. Each test was done in 






5.2.7   Blow Spinning Fibers  
 A mixture of 10 mL dichloromethane (DCM), PLA, and mHNTs were combined and 
ultrasonicated for 20min. The solution was then left for 48 hr at room temperature. A 
Zeny gravity feed airbrush kit was used with the air pump set to maintain a constant 
pressure of 40-60psi as our blow spinner. A square (4in x 4in) of sterile gauze as attached 
to the spraying platform. 4 mL of the DCM/PLA/mHNT solution was evenly airbrushed 
onto the surface of the gauze. The gauze was fully dry overnight at room temperature. 
Two squares were placed together with the airbrushed sides facing each other to make a 
four-layer filter. An unsprayed gauze square was used to sandwich the blow-spun layer of 
another gauze square to make a three-layer filter.      
5.2.7.1  Blow-Spun Fiber Concentrations 
 Three different mixtures of DCM, PLA, and mHNT were used to compare the 
surface’s appearance to determine which was more uniformed. Each mixture contained 
10 mL of DCM and varying amounts of PLA and mHNT. The concentrations of PLA in 
DCM were 0.1 g/mL, 0.075 g/mL, and 0.05 g/mL. Each mixture contained twenty 
percent mHNT by weight concerning the amount of PLA. Using 4 mL of the solution, 
theoretically 400 mg, 300 mg, and 200 mg of PLA with 80 mg, 60 mg, and 40 mg of 
mHNT was deposited onto each square of gauze respectively.  
5.2.7.2  Blow-Spun Fibers with Varying Amounts of mHNTs 
 Filters with varying amounts of mHNTs were made to test the dispersion of copper 
across the surface of the filters. 10 mL of DCM was added to three 50 mL glass vials 
along with 500 mg of PLA. 50 mg, 100 mg, and 150 mg of CuHNTs were added to each 





each solution was blow-spun onto a 4x4 inch gauze square and allowed to dry at room 
temperature for 24 hours before analysis.   
 5.2.8   Distribution of mHNTs in the Filter 
 The blow-spun fibers using PLA, dichloromethane and mHNTs were blown onto 
gauze, an analysis of the distribution of mHNTs was performed. SEM and EDS imaging 
were used to examine the fibers and map the distribution of the mHNTs on the surface of 
the blow-spun material.  
5.2.9   Filter Imaging 
5.2.9.1  Scanning Electron Microscope (SEM)  
 The mHNTs and filters were imaged with the SEM to characterize the texture of 
the surface. The filters’ surface topography will give an insight into how the blow-spun 
fibers are oriented and show prominent pores near the surface. SEM images will confirm 
that the HNTs are coated with metal nanoparticles.  
5.2.9.2  Energy Dispersion Spectroscopy (EDS) 
 The mHNTs and filters were imaged and analyzed with the EDS to further 
characterize the texture of the surface and show the dispersion of metal on their body. 
The distribution of metal on the surface of the filters can be displayed and quantified to 
represent the entirety of the filter. The EDS will confirm and quantify that the mHNTs 








5.3.1  SEM of mHNTs 
 
Figure 5-2: Scanning electron microscope image of A) silver, B) copper, and C) zinc 
coated halloysite nanotubes.  
 The SEM images shown in Figures 5-2 A-C show a thin, uniformed coating of metal 
on the outside surface of the HNTs. Excess agglomerated zinc particles were seen in the 
image. These particles were unable to be washed away using additional washing. The 







5.3.2   EDS of mHNTs  
 
Figure 5-3: Energy dispersion X-ray spectroscopy scan of A) silver, B) copper, and C) 
zinc coated halloysite nanotubes.  
 EDS analysis of the highlighted boxes Figure 5-5 A-C revealed a quantitative weight 
of ~6% for silver nanoparticles, ~5% for copper nanoparticles, and ~8% for zinc 
nanoparticles. Due to the unpredictable nature of the metal coating process, a variance in 
the amount of coating per nanotube is not unpredictable. Large clusters of copper and 
zinc nanoparticles were not observed as seen previously in silver samples.  
5.3.3  Liquid Growth Inhibition Studies 
The absorbance values for each Mueller-Hinton broth culture were measured at 
630 nm. The results for the 48h mHNT coated PLA beads are shown in Figure 5-4. The 
optical densities for the 24h and 48h bacteria cultures in Mueller-Hinton broth that 
contained GS doped mHNT coated PLA beads are shown in Figure 5-5 and Figure 5-6. 
Figure 5-7 and Figure 5-8 show E. coli and S. aureus’s growth pattern when exposed to 
PLA beads coated in GS doped mHNTs. Optical density is directly correlated to the 
turbidity of the broth. Higher turbidity is evidence of a higher amount of bacterial growth. 
As such, the control broth for each set of cultures yielded the highest optical densities. 





The optical densities for the 24h and 48h bacteria cultures in Mueller-Hinton 
broth that contained GS doped mHNT 3D printed discs are shown in Figure 5-9 and 
Figure 5-10. Figure 5-11 and Figure 5-12 show the growth pattern of E. coli and S. 
aureus when exposed to GS doped mHNTs discs. A higher turbidity was also observed in 
both cultures when using GS doped mHNT discs. 
In the experiments done with GS doped mHNT covered PLA beads and 3D 
printed GS doped mHNT embedded PLA discs, the cultures were also done with HNT 
covered PLA beads and 3D printed PLA embedded with HNT to see the effects of plain 
HNTs on bacterial growth. The resulting studies showed little to no growth inhibition of 
either E. coli or S. aureus. The GS doped mHNT coated beads showed little to no 
bacterial growth after an incubation period of 24h and 48h. The results of the bacterial 
studies done with 3D printed GS doped mHNT embedded PLA discs showed a higher 







Figure 5-4: PLA beads coated with mHNTs in Mueller-Hinton broth for 48h with E. coli 
or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent ± 
standard deviation. Values had a significant difference unless denoted (p<0.05). (n=3) 
 
Figure 5-5: PLA beads coated with doped mHNTs in Mueller-Hinton broth for 24h with 
E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent 























































Figure 5-6: PLA beads coated with doped mHNTs in Mueller-Hinton broth for 48h with 
E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent 
± standard deviation. Values had a significant difference unless denoted (p<0.05). (n=3) 
          
Figure 5-7: PLA beads coated with GS doped mHNTs in Mueller-Hinton broth for 
48h with E. coli. Optical density readings were taken at 0, 24, and 48h. Optical 





























































           
Figure 5-8: PLA beads coated with GS doped mHNTs in Mueller-Hinton broth for 
48h with S. aureus. Optical density readings were taken at 0, 24, and 48h. Optical 
density was taken at 630nm wavelength. Error bars represent ± standard deviation. 
(n=3) 
 The 3D printed PLA discs were subjected to identical testing conditions as the mHNT 
and GS doped mHNT coated beads. The results can be seen in Figures 5-9 through 5-12.   
 
Figure 5-9: GS doped 3D printed mHNTs discs in Mueller-Hinton broth for 24h with E. 
coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent ± 































































Figure 5-10: GS doped 3D printed mHNTs discs in Mueller-Hinton broth for 48h with E. 
coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent ± 
standard deviation. Values had a significant difference unless denoted (p<0.05). (n=3) 
          
Figure 5-11: 3D printed PLA with GS doped mHNTs in Mueller-Hinton broth for 
48h with E. coli. Optical density readings were taken at 0, 24, and 48h post 
inoculation. Optical density was taken at 630nm wavelength. Error bars represent ± 



























































          
Figure 5-12: 3D printed PLA with GS doped mHNTs in Mueller-Hinton broth for 
48h with S. aureus. Optical density readings were taken at 0, 24, and 48h post 
inoculation. Optical density was taken at 630nm wavelength. Error bars represent ± 
standard deviation. (n=3) 
5.3.4   Plate Growth Inhibition Studies 
 The zone of inhibition for undoped mHNTs in PLA discs is displayed in Figure 
5-13. The pictures from Figure 5-14 and 5-15 display the zone of inhibition of the 
different formulations of 3D printed GS loaded mHNT PLA discs. A positive control 
lawn of bacteria was used for both E. coli and S. aureus to display the ability to grow on 
the Mueller-Hinton agar plates. Each control plate had full coverage across the entire 
surface. A PLA disc embedded with plain HNTs was also plated to show any 
antibacterial properties of plain HNTs. Figure-16 shows the average zone of inhibition 






































Figure 5-13: Zone of inhibition diameter average for each respective 3D printed discs 
after 24h. Error bars represent ± standard deviation. Values had a significant difference 
unless denoted (p<0.05). (n=3) 
 
Figure 5-14: Mueller-Hinton agar plates, plated with E. coli, and (A) nothing, (B) 
PLA/HNT, (C) 3D printed GS/Ag/HNT disc, (D) 3D printed GS/Cu/HNT disc, (E) 
































Figure 5-15: Mueller-Hinton agar plates, plated with S. aureus, and (A) nothing, (B) 
PLA/HNT, (C) 3D printed GS/Ag/HNT disc, (D) 3D printed GS/Cu/HNT disc, (E) 3D 
printed GS/Zn/HNT disc, (F) 3D printed GS/Ag,Cu,Zn/HNT disc. 
 
Figure 5-16: Zone of inhibition diameter average for each respective 3D printed 
discs after 24h. These were GS loaded mHNTs. Error bars represent ± standard 

































5.3.5   Filter SEM and EDS 
 
Figure 5-17: SEM of filter using the 0.1g/mL mixture PLA solution.  
 






Figure 5-19: SEM of filter using the 0.05g/mL mixture PLA solution.  
 Fast scan SEM imaging was used to obtain the above images. Slower scanning 
or higher amounts of scans would have deformed the filter due to thermal energy 
imposed upon by the electron emitted from the SEM. 
 






Figure 5-21: EDS of 20% CuHNT to PLA blow-spun fibers. 
 






Figure 5-23: Graph showing the coverage of representative piece of each filter. 
Error bars represent standard deviation. Values had a significant difference unless 
denoted (p<0.05). (n=3) 
5.4 Discussions 
5.4.1   Analysis of GS/mHNTs 
 The EDS scans confirmed the addition of each metal to the surface of the halloysite 
nanotube. The color rendered images illustrated that each metal was deposited evenly on 
all nanotubes and was on the surface even after vacuum loading with gentamicin. 
Minimal contamination of unbound nanoparticles was observed. The presence of high 
concentrations of each specific metal nanoparticle in the area exhibiting high 
concentrations of the halloysite’s outer surface’s silicone confirmed this result. In 
samples with high amounts of contamination, large pockets of agglomerated 
nanoparticles with little to no silicone present.   
5.4.2   Antibacterial Studies 
The antibacterial capabilities of mHNTs and GS doped mHNTs were tested in a 

























of mHNT show a hindrance to bacterial growth. Vacuum loading mHNTs with GS 
offered a more remarkable ability to inhibit bacterial growth. As seen in Figures 2 and 3, 
the non-3D printed GS loaded mHNT coated PLA beads could better inhibit bacterial 
growth than the 3D printed GS loaded mHNT discs. We speculate that since the entire 
load of GS loaded mHNTs was on the surface of the beads, more of the nanoparticles and 
gentamicin were available to deter bacterial growth. The 3D printed discs were made 
with extruded filament containing the GS loaded mHNTs. The GS loaded mHNTs were 
dispersed within the filament and thus mainly within the 3D printed discs. With the 
nature of the dispersion, some GS loaded mHNTs were present on the 3D printed disc’s 
surface to inhibit bacterial growth. We observed that the GS loaded mHNTs could inhibit 
bacterial growth more than the gentamicin control disc. It is believed that the synergy of 
the loaded gentamicin and the metal nanoparticles made this possible.     
While the coated beads performed better than the 3D printed discs, they will lose 
their ability to be an effective bacterial deterrent over time. The nature of the 3D printed 
discs is such that they wear down over time. This wearing effectively discards the now 
empty mHNTs and exposed new ones to the surface thus keeping its antimicrobial 
properties. The principle of a renewed antimicrobial outer surface has benefits for 
manufacturing products like masks, light switches, and toilet handles. The advent of 
utilizing this technology to manufacture objects with questionable sanitation could lower 
the ability to transmit microorganisms.  
Medical facilities, such as hospitals or clinics, could see the most benefit from 
using antimicrobial surfaces to help fight the spread of infections like MRSA. Surfaces 





surfaces are not cleaned. Surfaces such as doorknobs, water fountains, and water faucet 
handles are often touched with little second thought to the possible transfer of germs. An 
innate ability to self-sanitize would provide considerably better protection to all who 
come into contact.  
To produce the quantity needed for mass implementation, two manufacturing 
methods can be used, industrial 3D printers or injection molding. Each technique of mass 
manufacturing has its advantages and disadvantages. The benefits of industrial 3D 
printing are the rapid ability to change the design of the object being printed. The 
obstacles that are faced with industrial 3D printing are the slow turnover and increased 
porosity. Injection molding has a faster throughput but can typically be harder to adjust 
the design.  
The GS doped mHNTs and their antimicrobial capabilities can be used to 
manufacture more than the face masks and filters tested in this study. Intubation tubes 
and catheters can be manufactured with mHNTs to reduce infections in patients caused 
by bacterial. Eye guards have been made using mHNTs embedded in polycarbonate or 
poly (methyl methacrylate). Clarity was not compromised by implementing the mHNTs 
and showed an improvement in strength and antimicrobial capability. Research continues 
to be conducted to discover more products that can benefit from the implementation of 
mHNTs. 
5.4.3   Filter Construction 
 The SEM images show that the fibers of the filter are long and interwoven 
strands. The blow-spun fibers’ complex structure reduces the filter’s porosity, allowing it 





different concentrations revealed that a higher concentration of PLA in solution would 
yield a blotchy, uneven spray pattern instead of fine, uniformed fibers.   
The EDS images show that we have an even distribution of mHNTs on the 
surface of the filter. The concentration of mHNT on the surface went up as predicted with 
higher concentrations of mHNT in solution, with minimal adverse effects such as area 
agglomeration. We concluded that the blow-spun fibers at the surface represent the 
internal fibers of the filter. With each pass of the airbrush, an additional layer is added of 
seemingly the same fiber dispersion.  
The EDS images in Figure 5-20, 5-21, and 5-22 showed an even distribution of 
CuHNTs filter’s surface. The blow-spun fibers beyond the surface should exhibit similar 
patterns of distribution. The varying concentration of CuHNTs influenced the number of 
deposited mHNTs. Darkfield analysis of the EDS images showed a decline in the overall 
darkness as the concentration of CuHNT increased, meaning more copper was present. 
Analysis of the overall intensity of the EDS images of multiple filters revealed that the 
coverage of mHNT when using 20% and 30% were similar. The precent of coverage can 
be seen in Figure 5-23. These combined results mean the 30% CuHNT was applied more 
evenly across the surface. This could be due to having a more homogeneous starting 
mixture or merely human error when blow spinning.  
5.5 Conclusions 
3D printing has emerged as a viable option to manufacture face masks. The 
critical design feature in N95 respirators and surgical masks is the filtration unit. We have 
an efficient and effective design using 3D printing that can be scaled up for mass 





the capability of our antimicrobial filament to be used to manufacture a mask that has 
antibacterial capabilities. GS loaded mHNTs were successfully used to effectively kill or 
retard the growth of both gram-negative and gram-positive bacteria on a surface and in 
liquid mediums. Mueller-Hinton broth optical density and Mueller-Hinton agar plate 
zone of inhibition results support this conclusion. While the mHNTs showed an ability to 
hinder bacteria’s growth, the GS-doped mHNTs offered a much greater capacity to kill or 
inhibit bacterial growth. Due to the nature of the filament manufacturing and the 3D 
processes, careful consideration was taken when choosing the antimicrobial agent used as 
a dopant. 
Recent concerns about the effectiveness of 3D printed face masks and respirators 
have arisen in response to similar designs to our “Montana style mask” made on 
commercially available printers. The two major concerns are that the mask’s fit is not 
adequate, and the filter is not secured tight enough. We modified the original design of 
the Montana mask to address these issues. We added a layer of soft material to the 
masks’ edge to improve comfort and provide a better seal to the wearer’s face. The soft 
fabric was made of silicon weather stripping that was glued into place. A rubber foam 
material was not used due to porosity and complications with future sanitation. The 
silicon can be sanitized with UV light, soap, alcohol, or hydrogen peroxide solutions. The 
filter seal was improved by the addition of a small lip onto the front of the mask. The lip 
would act as a guard in which you could tightly push the filter and filter guard against the 
front of the mask, making a better seal.  
 Future studies will explore alternative doping materials to customize filament to 





many more within the PLA filament. The addition of different metal nanoparticles and 
multiple types of metal nanoparticles to a single HNT could improve the PLA filament’s 
antibacterial capabilities. Polyethylene terephthalate glycol (PETG) will be explored as 
an alternative option to PLA because it is more robust and durable.   
The respirator will soon undergo National Institute of Occupational Safety and 
Health (NIOSH) certified fit testing to ensure it passes government regulations for 
occupational use within the United States of America. Antiviral studies will be conducted 
using two surrogate coronaviruses, mouse hepatitis virus (MHV) and transmissible 
gastroenteritis virus (TGEV). Testing will include viral elimination on the filter’s surface 
that will be analyzed using an ELISA kit. Additionally, the filter will be tested using a 
nebulized virus in a vacuum system to gauge the effectiveness of stopping viral particles 
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